Tap any paragraph to write a margin note. Your notes collect in the Desk below the text and file under cases with @. The side-by-side margin rail opens on a larger screen.

§
Marginalia
Code · REGISTER · 2008-07-17 · Office of Governmentwide Policy, General Services Administration (GSA) · Notices

Notices. Notice

22,816 words·~104 min read·/register/2008/07/17/08-1444

A research copy — for the controlling text, always check the official state or federal source. Not legal advice.

BILLING CODE 6760-01-P GENERAL SERVICES ADMINISTRATION 2008 Travel and Relocation Innovation Award AGENCY: Office of Governmentwide Policy, General Services Administration (GSA). ACTION: Notice. SUMMARY: The General Services Administration
(GSA)is announcing an extended nominations entry date for the 2008 Travel and Relocation Innovation Award. This award will recognize masters of travel and/or relocation management. FOR FURTHER INFORMATION CONTACT: Go to GSA's 2008 Travel and Relocation Innovation Award at *www.gsa.gov/travelrelocationaward* or contact Jane Groat, Travel Management Policy, Office of Travel, Transportation, and Asset Management (MT), General Services Administration, Washington, DC 20405,
(202)501-4318, *jane.groat@gsa.gov* . SUPPLEMENTARY INFORMATION: The Federal Travel Regulation is contained in Title 41 Code of the Federal Regulations (41 CFR Chapters 300 through 304), and implements statutory requirements and Executive branch policies for travel and relocation by Federal civilian employees and others authorized to travel and relocate at Government expense. GSA announces an award to recognize and honor excellence in Federal travel and relocation. This award, available to all Federal employees, will honor individuals and/or teams. In addition to cash awards, one or more entries may receive honorable mention. Entries must be received no later than August 29, 2008. Dated: July 10, 2008. Patrick McConnell, Acting Director, Travel Management Policy. [FR Doc. E8-16355 Filed 7-16-08; 8:45 am] BILLING CODE 6820-14-S GENERAL SERVICES ADMINISTRATION Federal Travel Regulation (FTR); Reimbursement of Fees Associated with Airport Security Fast Pass Memberships; Notice of GSA Bulletin FTR 08-05 AGENCY: Office of Governmentwide Policy, General Services Administration (GSA). ACTION: Notice of a bulletin. SUMMARY: On June 25, 2008, the General Services Administration
(GSA)issued a bulletin to inform agencies that fees for individual employee memberships in registered and/or trusted traveler programs ( *i.e.* , FlyClear) are not allowable expenses or reimbursements for purposes of Federal government travel under the Federal Travel Regulation (FTR). That bulletin, FTR Bulletin 08-05, may be found at *www.gsa.gov/bulletins* . DATES: The bulletin announced in this notice is effective June 25, 2008, and is applicable to official Federal travel performed on or after June 25, 2008. FOR FURTHER INFORMATION CONTACT Ms. Jane Groat, Office of Governmentwide Policy (M), Office of Travel, Transportation, and Asset Management (MT), General Services Administration at
(202)501-4318 or via e-mail at *jane.groat@gsa.gov* . Please cite FTR Bulletin 08-05. Dated: July 10, 2008. Patrick McConnell, Acting Director, Travel Management Policy. [FR Doc. E8-16356 Filed 7-16-08; 8:45 am] BILLING CODE 6820-14-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Agency Information Collection Activities: Proposed Collection; Comment Request AGENCY: Agency for Healthcare Research and Quality, HHS. ACTION: Notice. SUMMARY: This notice announces the intention of the Agency for Healthcare Research and Quality
(AHRQ)to request that the Office of Management and Budget
(OMB)approve the proposed information collection project: “Health Care Systems for Tracking Colorectal Cancer Screening Tests.” In accordance with the Paperwork Reduction Act of 1995, 44 U.S.C. 3506(c)(2)(A), AHRQ invites the public to comment on this proposed information collection. This proposed information collection was previously published in the **Federal Register** on March 27th, 2008 and allowed 60 days for public comment. No comments were received. The purpose of this notice is to allow an additional 30 days for public comment. Changes were made to this 30 day notice to account for the electronic patient records review which were not accounted for in the 60 day notice. DATES: Comments on this notice must be received by August 18, 2008. ADDRESSES: Written comments should be submitted to: AHRQ's OMB Desk Officer by fax at
(202)395-6974 ( *attention:* AHRQ's desk officer) or by e-mail at *OIRA_submission@omb.eop.gov* (attention: AHRQ's desk officer). Copies of the proposed collection plans, data collection instruments, and specific details on the estimated burden can be obtained from the AHRQ Reports Clearance Officer. FOR FURTHER INFORMATION CONTACT: Doris Lefkowitz, AHRQ Reports Clearance Officer,
(301)427-1477, or by e-mail at *doris.lefkowitz@ahrq.hhs.gov.* SUPPLEMENTARY INFORMATION: Proposed Project Health Care Systems for Tracking Colorectal Cancer Screening Tests AHRQ proposes to implement and assess a system redesign intervention to improve colorectal cancer
(CRC)screening and follow-up among patients 50-79 years-old. Other goals of the intervention include:
(1)Achieving a high level of satisfaction with the intervention among patients, providers, and practice staff,
(2)promoting patient-centered care through the intervention,
(3)being a cost-effective intervention, and
(4)demonstrating the benefits to businesses for implementing the intervention. The research is sponsored by AHRQ under its ACTION (Accelerating Change and Transformation in Organizations and Networks) program, and will be conducted for AHRQ by The CNA Corporation
(CNA)and its partners Thomas Jefferson University
(TJU)and Lehigh Valley Hospital (LVH). Colorectal cancer screening is recommended as routine preventive care and this intervention, which is consistent with current CRC screening guidelines, carries no greater risk than that which occurs in usual delivery of healthcare (i.e., screening and follow up done without benefit of this intervention). Nevertheless, as part of standard research practice, the intervention and assessment protocol will be submitted to the Institutional Review Boards
(IRB)at both LVH and TJU so that they can review the protocols to ensure that they are consistent with the requirements of human subjects protection as outlined in federal statute, regulations, and guidelines. These approvals will be obtained before the study begins. Additionally, CNA and LVH have a business associate agreement, and all parties involved with the study (CNA, LVH, and TJU) will comply with the Health Insurance Portability and Accountability Act (HIPAA) Privacy Rule, 45 CFR parts 160 and 164. To further protect patient privacy, neither CNA nor TJU will have access to any personally-identifiable data. Only LVH personnel will have access to identifiable data, which they will de-identify before sending to CNA and TJU for analysis. Consistent with this protocol, only LVH staff will have access to patient names and addresses and will conduct all mailings of letters and related material to patients. The intervention will be implemented in both Family Medicine and General Internal Medicine practices affiliated with the LVH, and will involve 20 intervention practices and 5 control practices (25 practices total). The intervention will consist of inviting and assisting eligible patients of intervention practices to be screened for CRC, providing academic detailing to intervention practice providers regarding CRC screening and appropriate follow-up for positive screens, and assisting providers to identify and follow up with their patients who have positive screens. Many of the practices within LVH, are part of four large practice entities—Medical Associates of The Lehigh Valley (MATLV, a large, private group association), Lehigh Valley Physicians Group (LVPG, hospital-owned practices), Lehigh Valley Physician Hospital Organization (LVPHO, a physician hospital organization that provides physician practice services and health insurance products), and practices which jointly use Physician Business Services
(PBS)for billing and associated activities. The electronic data used during the records review (claims and billing records, and electronic medical records when available) will be centrally extracted by only four entities (LVPHO, MATLV, LVPG, and PBS). These entities will have access to their own patients' data. LVH study personnel will then merge these data to develop the central patient database for this study. This central patient database will contain information on all intervention practice patients ages 50-79 identified as being potentially eligible for the intervention. Patient eligibility criteria for the intervention include: Being between the ages of 50-79, having no recent CRC screening test, not having a previous diagnosis of CRC, and not having a family history of CRC before age 60. Eligible patients will be identified through a two step process:
(1)An electronic records review to identify potentially eligible patients; and
(2)a mailed Screening Eligibility Assessment
(SEA)form from their primary care practice to allow potentially eligible patients to confirm or refute their eligibility, and provide selected additional demographic and perceived health status information. Patients will also have the opportunity to opt out of the study on the SEA form. Patients who are deemed eligible and have not opted out of the study through the SEA form will then receive a mailing from their practice inviting them to be screened for colorectal cancer. The invitation will include a letter on practice letterhead signed by the practice's primary care providers, a brochure that describes the benefits of CRC screening and the alternative screening modalities that are consistent with American Cancer Society guidelines, a stool test kit with an envelope to return it for processing for those patients who want to use that screening modality, and a list of colonoscopists that the practice refers patients to for those patients who prefer colonoscopy to a stool test. In addition to the list of colonoscopists, the accompanying letter from the practice will also include wording to make sure patients are aware they can select other colonoscopists who may not be on the list. As this invitation mailing is part of normal recommended clinical practice and requires no response on the part of the patient other than participating in the clinically recommended screening, it is not considered to be a data collection. Patient electronic records will be tracked by LVH personnel for evidence of screening. Patients whose records do not indicate they have been screened within a certain amount of time will be sent a reminder letter. As with the invitation mailing, this reminder mailing is part of normal recommended clinical practice and requires no response on the part of the patient other than participating in the clinically recommended screening, and is not considered to be a data collection. There will be no additional cost to patients for CRC screening beyond that which occurs in the usual delivery of health care. Patients insured through a LVPHO insurance product will be covered for diagnosis and treatment. Patients covered through non-LVPHO plans (public as well as private) will also likely be covered, and such coverage will be documented to determine its impact on the effectiveness of the intervention. Patients who are underinsured or uninsured are eligible to use systems for charity and discounted care available in the Lehigh Valley Hospital and Healthcare Network, including access to hospital clinics and access to financial advisors. Clinicians and staff of intervention practices will participate in a brief academic detailing session to review the current evidence-based guidelines for CRC screening from the American Cancer Society, to receive information regarding appropriate follow-up to positive screens, and to receive the operational details of the implementation that will affect the practice (including being provided information about the intervention that may be necessary for answering questions from patients). Academic detailing will not be provided to control practices. As educational information is only being provided, this component of the intervention is not a data collection. Method of Collection Data will be collected through seven modes:
(1)Electronic patient records review;
(2)a SEA form;
(3)focus groups of providers and staff at each intervention and control practice;
(4)brief informal interviews with selected providers and staff at each practice;
(5)a survey of all clinicians and staff at each practice;
(6)patient chart audits; and
(7)patient focus groups. The data will be collected to obtain the following types of information needed for determining patient eligibility for the intervention and for conducting an assessment of the intervention: Patient's screening history and eligibility information; patient demographics; patient, provider, and practice satisfaction with the intervention; practice attitudes; practice procedures and systems for screening and tracking results; and patient-perceived barriers and facilitators for following screening and follow-up recommendations. Electronic Patient Records Review An electronic records review will be used to identify patients who are potentially eligible to participate in this study based on the study's eligibility criteria. The electronic records will be extracted from only four entities—LVPHO, MATLV, LVPG, and PBS. Electronic records review will also be used part way through the intervention period for patients of intervention practices to determine who should receive a follow up reminder letter, and then again at the conclusion of the intervention period for patients of both intervention and control practices to determine which patients have completed a stool test or colonoscopy and whether patients who screened positive received appropriate follow up diagnostic evaluation. SEA Form Potentially eligible patients identified by electronic records review will receive a SEA form and accompanying letter. This form will ask patients to confirm or refute their eligibility based on all eligibility criteria. The form will also ask patients for additional socio-demographic and perceived health status data, and allow patients to opt out of participation in the intervention if they so choose. Practice Focus Groups The practice focus groups will be conducted both prior to the intervention and following the intervention at each intervention practice. The pre-intervention focus groups are designed to collect information to establish a baseline. The post-intervention focus groups will be conducted to assess satisfaction with the intervention and to identify changes in attitudes and behaviors regarding screening and follow-up and changes in management of normal and abnormal screening tests resulting from the intervention. In addition, focus groups at control practices will be conducted late in the intervention period to gather comparison information similar to the baseline information gathered from intervention practices. Brief Informal Interviews Brief informal interviews with selected intervention practice providers and staff will be conducted as a follow-up to the focus groups to ascertain additional baseline information about procedures and systems for screening results (pre-intervention), and additional information about each practice's experience with the intervention and facilitators and barriers to the intervention's implementation (post-intervention). In addition, similar baseline information will be collected from control practices late in the intervention period. Practice Survey A pre-intervention practice survey of providers and staff will be administered in the intervention practices to provide a baseline of the current CRC screening environment at each practice. The survey will be administered again post-intervention to ascertain changes in behavior or attitudes resulting from the intervention. In addition, the survey will also be administered in the control practices late in the intervention period to gather comparison information similar to the baseline information gathered from intervention practices. Patient Chart Audits Study personnel will track patient screening rates and outcomes as well as follow-up rates at intervention and control practices by conducting chart audits on patients whose electronic data are inconclusive, or on patients who are part of practices without electronic medical records
(EMR)systems. Chart audits will be performed by LVH study personnel; however, practice staff will be required to identify, locate, and make charts available to study personnel. Patient Focus Groups Focus groups of patients will be conducted to better understand the intervention from the patient's perspective. Focus groups with the intervention practices will be held at two sites geographically situated across the region. At each site, three focus groups will be conducted for each of the following types of intervention patients:
(1)Those who did not get the recommended screening after receiving the invitation packet,
(2)those who did get the recommended screening and whose test was negative, and
(3)those who did get screened and whose test was positive. For purposes of comparison, two focus groups of patients from control group practices will also be conducted. Participants will be asked about their attitudes and beliefs regarding colorectal cancer screening and what they believe would help them get the screening they need. Estimated Annual Respondent Burden Exhibit 1 shows the estimated annualized burden hours for the respondents to participate in this project. The electronic patient records review will be performed by only four entities (LVPHO, MATLV, LVPG, and PBS) which will each extract approximately 1,875 records, requiring about 68 hours total. The SEA form will be sent to a maximum of 7,500 patients across the 20 intervention practices and will require an average of 10 minutes to complete each. Practice focus groups will be conducted with 10 individuals per practice, and will last approximately 30 minutes each. The pre-intervention and post-intervention practice focus groups will be held with intervention practices only (20 practices). Focus groups will also be held at each of the control practices for comparison purposes (5 practices). Informal interviews will be conducted with three individuals per practice, and will last about 10 minutes each. The pre and post-intervention informal interviews will be conducted among the intervention practices (20 practices). Informal interviews will also be conducted in the control practices for comparison purposes (5 practices). A survey of providers and staff will be conducted with 10 individuals at each practice, and the survey will take approximately 15 minutes to complete. The survey will be administered to the intervention practices during the pre and post-intervention practice focus group (20 practices). The survey will also be administered to the control practices for comparison purposes (5 practices). Patient chart audits will be performed post-intervention at both intervention and control practices as a supplement to the information available through electronic records. Among the 25 practices, about 50 patients from each practice will have their charts audited, which should take about 10 minutes per chart. Patient focus groups will be held post-intervention and will include six groups of 10 patients from the intervention group practice sites, and two groups of 10 patients from the control group practice sites (80 patients total). These focus groups are expected to last about 2 hours. The total burden for all phases of the project is estimated to be 2,046.33 hours. Exhibit 2 shows the estimated annualized cost burden for the respondents' time to participate in the project. The total cost is estimated to be $31,446.73. Exhibit 1.—Estimated Annualized Burden Hours Data collection mode Number of respondents Number of responses per respondent Est. time per respondent (in hours) Total burden hours Electronic patient record review* 4 3 5.66 68 Screening Eligibility Assessment
(SEA)Form 7,500 1 10/60 1250 Pre-intervention practice focus groups 20 10 30/60 100 Post-intervention practice focus groups 20 10 30/60 100 Control practice focus groups 5 10 30/60 25 Pre-intervention informal interviews with selected providers and staff 20 3 10/60 10 Post-intervention informal interviews with selected providers and staff 20 3 10/60 10 Control informal interviews with selected providers and staff 5 3 10/60 2.5 Pre-intervention survey of clinicians and staff 20 10 15/60 50 Post-intervention survey of clinicians and staff 20 10 15/60 50 Control survey of clinicians and staff 5 10 15/60 12.5 Chart audits 25 50 10/60 208.33 Patient Focus Groups (post-intervention) 80 1 2 160 Total 7,744 2,046.33 *In the intervention practices, electronic records review will be conducted pre-intervention, mid-intervention, and post-intervention. Mid-intervention electronic records review will be conducted in order to determine which patients should be sent the Reminder Letter if they have not yet completed a stool test kit or colonoscopy. In the control practices, electronic records review will be conducted pre-intervention and post-intervention. The electronic records review will be performed by administrative assistants (16 of 68 burden hours) and data analysts (52 of 68 burden hours). Exhibit 2.—Estimated Annualized Cost Burden Data collection mode Number of respondents Total burden hours Average hourly wage rate* Total cost burden Electronic patient record review 4 68 $23.56 $1,602 Screening Eligibility Assessment
(SEA)Form 7,500 1,250 12.54 15,675 Pre-intervention practice focus groups 20 100 28 2,800 Post-intervention practice focus groups 20 100 28 2,800 Control practice focus groups 5 25 28 700 Pre-intervention informal interviews with selected providers and staff 20 10 28 280 Post-intervention informal interviews with selected providers and staff 20 10 28 280 Control informal interviews with selected providers and staff 5 2.5 28 70 Pre-intervention survey of clinicians and staff 20 50 28 1,400 Post-intervention survey of clinicians and staff 20 50 28 1,400 Control survey of clinicians and staff 5 12.5 28 350 Chart audits 25 208.33 10 2,083.33 Patient Focus Groups (post-intervention) 80 160 12.54 2,006.40 Total 7,744 2,046.33 31,446.73 * Wage rates were calculated using the following data:
(1)For the electronic patient record review the hourly rate is a weighted average for administrative assistants ($14.00 per hour) and data analysts ($26.50 per hour);
(2)for the SEA form and patient focus groups the patient average hourly wage was based on the average per capita income of $26,088 (computed into an hourly wage rate of $12.54) in Lehigh Valley, Pennsylvania: “Demographic Information for the Lehigh Valley” from the Lehigh Valley Economic Development Corporation 2006;
(3)for the practice focus groups, informal interviews, and survey the provider and practice hourly wage was based on an average of the following estimates from LVH—physician = $70/hour; manager = $19/hour; clinical staff = $13/hour; and clerical staff = $10/hour;
(4)for the chart audits the practice clerical staff hourly wage was estimated by LVH to be $10/hour (note: practice clerical staff will retrieve the charts to be audited by study personnel; therefore only the time of the practice clerical staff is included in Exhibit 1 and in the Exhibit 2 cost estimate). Estimated Annual Costs to the Federal Government The estimated total cost to the Federal Government is $271,764.68. The average annualized cost over the two years of the project is $135,882.34 per year. Exhibit 3 shows a breakdown of the costs. Exhibit 3.—Estimated Annual Costs to the Federal Government Component Year 1 Year 2 Total The cost of developing the data collection instruments $24,765.38 $0 $24,765.38 The cost of implementing the data collections 99,061.52 24,601.75 123,663.27 The cost of analyzing the data and publishing the results 49,530.76 73,805.26 123,336.02 Total 173,357.66 98,407.02 271,764.68 Request for Comments In accordance with the above-cited Paperwork Reduction Act legislation, comments on AHRQ's information collection are requested with regard to any of the following:
(a)Whether the proposed collection of information is necessary for the proper performance of AHRQ health care research and health care information dissemination functions, including whether the information will have practical utility;
(b)the accuracy of AHRQ's estimate of burden (including hours and costs) of the proposed collection(s) of information;
(c)ways to enhance the quality, utility, and clarity of the information to be collected; and
(d)ways to minimize the burden of the collection of information upon the respondents, including the use of automated collection techniques or other forms of information technology. Comments submitted in response to this notice will be summarized and included in the Agency's subsequent request for OMB approval of the proposed information collection. All comments will become a matter of public record. Dated: June 27, 2008. Carolyn M. Clancy, Director. [FR Doc. E8-15666 Filed 7-16-08; 8:45 am] BILLING CODE 4160-90-M DEPARTMENT OF HEALTH AND HUMAN SERVICES Agency for Healthcare Research and Quality Notice of Correction—Assessing the Impact of the Patient Safety Improvement Corps
(PSIC)Training Program With this correction notice, the Agency for Healthcare Research and Quality
(AHRQ)informs the public of changes made to a notice on “Assessing the Impact of the Patient Safety Improvement Corps
(PSIC)Training Program” published on June 24, 2008, Vol. 73, No. 122, pages 35692-35693 under section SUPPLEMENTARY INFORMATION . The revised subsections below on “Estimated Annual Respondent Burden, Exhibit 1 and 2” replace same subsections published on June 24, 2008. Estimated Annual Respondent Burden Exhibit I shows the estimated annualized burden hours for the respondent's time to participate in the study. Qualitative interviews will be conducted with a maximum of 54 individuals and will last about one hour. The training participant questionnaire is estimated to require 30 minutes to complete and the organizational leader questionnaire is estimated to require 15 minutes to complete, resulting in a total burden of 223 hours. Exhibit 1.—Estimated Annualized Burden Hours Form name Number of respondents Number of responses per respondent Hour per response Total burden hours Qualitative interview 54 1 1 54 Training participant questionnaire 300 1 30/60 150 Organizational leader questionnaire 75 1 15/60 19 Total 429 NA NA 223 Exhibit 2 shows the estimated annualized cost burden based on the respondents' time to participate in the study The total cost burden is estimated to be $7,453.06. Exhibit 2.—Estimated Annualized Cost Burden Form name Number of respondents Total burden hours Average hourly wage rate * Total cost burden Qualitative interview 54 54 $35.19 $1,900.26 Training participant questionnaire 300 150 32.18 4,827.00 Organizational leader questionnaire 75 19 38.20 725.80 Total 429 223 NA 7,453.06 * Based upon the mean of the average wages for health professionals for the training participant questionnaire and for executives, administrators, and managers for the organizational leader questionnaire presented in the National Compensation Survey: Occupational Wages in the United States, June 2005, U.S. Department of Labor, Bureau of Labor Statistics. Dated: July 3, 2008. Carolyn M. Clancy, Director. [FR Doc. E8-16062 Filed 7-16-08; 8:45 am] BILLING CODE 4160-90-M DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP): CDC Grants for Public Health Research Dissertation (Panel A-3), Program Announcement
(PAR)07-231 *Correction:* This notice was published in the **Federal Register** on June 12, 2008, Volume 73, Number 114, pages 33435-33436. The title should read as follows: *Disease, Disability, and Injury Prevention and Control Special Emphasis Panel (SEP):* CDC Grants for Public Health Research Dissertation (Panel A-1), Program Announcement
(PAR)07-231. *Contact Person for More Information:* Sheree Marshall Williams, Ph.D., M.Sc., Scientific Review Administrator, CDC, 1600 Clifton Road, NE., Mailstop D72, Atlanta, GA 30333, Telephone
(404)639-4896. The Director, Management Analysis and Services Office, has been delegated the authority to sign **Federal Register** notices pertaining to announcements of meetings and other committee management activities, for both CDC and the Agency for Toxic Substances and Disease Registry. Dated: July 9, 2008. Elaine L. Baker, Director, Management Analysis and Services Office, Centers for Disease Control and Prevention. [FR Doc. E8-16340 Filed 7-16-08; 8:45 am] BILLING CODE 4163-18-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request *Title:* Statewide Automated Child Welfare Information System (SACWIS) Assessment Review Guide (SARGE). *OMB No.:* 0970-0159. *Description:* HHS cannot fulfill its obligation to effectively serve the nation's Adoption and Foster Care populations, nor report meaningful and reliable information to Congress about the extent of problems facing these children or the effectiveness of assistance provided to this population, without access to timely and accurate information. Currently, SACWIS support State efforts to meet the following Federal reporting requirements: The Adoption and Foster Care Analysis and Reporting System (AFCARS) required by section 479(b)(2) of the Social Security Act; the National Child Abuse and Neglect Data System (NCANDS); Child Abuse Prevention and Treatment Act (CAPTA); and the Chafee Independent Living Program. These systems also support state efforts to provide the information to conduct the Child and Family Service Reviews. Currently, forty-two States and the District of Columbia have developed, or are developing, a SACWIS with Federal financial participation. The purpose of these reviews is to ensure that all aspects of the project, as described in the approved Advance Planning Document, have been adequately completed, and conform to applicable regulations and policies. To initiate a review, States will submit the completed SACWIS Assessment Review Guide (SARGE) and other documentation at the point that they have completed system development and the system is operational statewide. The additional documents submitted as part of this process should all be readily available to the State as a result of good project management practices. The information collected in the SACWIS Assessment Review Guide will allow State and Federal officials to determine if the State's SACWIS meets the requirements for title IV-E Federal Financial Participation
(FFP)defined at 45 CFR 1355.50. Additionally, other States will be able to use the documentation provided as part of this review process in their own system development efforts. *Respondents:* State Governments. Annual Burden Estimates Instrument Number of responses Number of responses per respondent Average burden hours per response Total burden hours Review 1 1 200 200 *Estimated Total Annual Burden Hours:* 200. *Additional Information:* Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L'Enfant Promenade, SW., Washington, DC 20447, Attn: ACE Reports Clearance Officer. All requests should be identified by the title of the information collection. E-mail address: *infocollection@acf.hhs.gov.* *OMB Comment:* OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the **Federal Register** . Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Fax: 202-395-6974, Attn: Desk Officer for the Administration for Children and Families. Dated: July 10, 2008. Janean Chambers, Reports Clearance Officer. [FR Doc. E8-16180 Filed 7-16-08; 8:45 am] BILLING CODE 4184-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request *Title:* Child Care and Development Fund Tribal Plan (Form ACF-118-A). *OMB No.:* 0970-0198. *Description:* The Child Care and Development Fund
(CCDF)Tribal Plan serves as the agreement between the applicant (Indian Tribes, tribal consortia and tribal organizations) and the Federal Government that describes how tribal applicants will operate CCDF Block Grant programs. The Tribal Plan provides assurances that the CCDF funds will be administered in conformance with legislative requirements, Federal regulations at 45 CFR parts 98 and 99 and other applicable instructions or guidelines issued by the Administration for Children and Families (ACF). Tribes must submit a new CCDF Tribal Plan every two years in accordance with 45 CFR 98.17. *Respondents:* Tribal CODE programs (259 total). Annual Burden Estimates Instrument Number of respondents Number of responses per respondent Average burden hours per response Total burden hours CCDF Tribal Plan 259 1 17.5 4,532.5 CCDF Tribal Plan Amendments 259 1 1.5 388.5 *Estimated Total Annual Burden Hours:* 4,921. *Additional Information:* Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L'Enfant Promenade, SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. All requests should be identified by the title of the information collection. E-mail address: *infocollection@acf.hhs.gov.* *OMB Comment:* OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the **Federal Register** . Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Fax: 202-395-6974, Attn: Desk Officer for the Administration for Children and Families. Dated: July 10, 2008. Janean Chambers, Reports Clearance Officer. [FR Doc. E8-16183 Filed 7-16-08; 8:45 am] BILLING CODE 4184-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES Administration for Children and Families Submission for OMB Review; Comment Request *Title:* The OC5E-157 Child Support Enforcement Annual Data Report. *OMB No.:* 0970-0177. *Description:* The information obtained from this form will be used to:
(1)Report Child Support Enforcement activities to the Congress as required by law;
(2)calculate incentive measures performance and performance indicators utilized in the program; and
(3)assist the Office of Child Support Enforcement in monitoring and evaluating State Child Support programs. *Respondents:* State, Local or Tribal Government. Annual Burden Estimates Instrument Number of respondents Number of responses per respondent Average burden hours per response Total burden hours OCSE-157 Child Support Annual Data Report 54 1 7 378. *Estimated Total Annual Burden Hours:* 378 *Additional Information:* Copies of the proposed collection may be obtained by writing to the Administration for Children and Families, Office of Administration, Office of Information Services, 370 L'Enfant Promenade, SW., Washington, DC 20447, Attn: ACE Reports Clearance Officer. All requests should be identified by the title of the information collection. E-mail address: *infocollection@acf.hhs.gov.* *OMB Comment:* OMB is required to make a decision concerning the collection of information between 30 and 60 days after publication of this document in the **Federal Register** . Therefore, a comment is best assured of having its full effect if OMB receives it within 30 days of publication. Written comments and recommendations for the proposed information collection should be sent directly to the following: Office of Management and Budget, Paperwork Reduction Project, Fax: 202-395-6974, Attn: Desk Officer for the Administration for Children and Families. Dated: July 10, 2008. Janean Chambers, Reports Clearance Officer. [FR Doc. E8-16197 Filed 7-16-08; 8:45 am] BILLING CODE 4184-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2005-D-0208] (formerly Docket No. 2005D-0438) Guidance for Industry: Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is announcing the availability of a document entitled “Guidance for Industry: Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency,” dated June 2008. The guidance document provides recommendations for the design of clinical trials to assess the safety, efficacy, and pharmacokinetics of immune globulin intravenous (human)
(IGIV)products as replacement therapy in primary humoral immunodeficiency. The guidance announced in this notice finalizes the draft guidance of the same title dated November 2005. DATES: Submit written or electronic comments on agency guidances at any time. Submit written requests for single copies of the guidance to the Office of Communication, Training, and Manufacturers Assistance (HFM-40), Center for Biologics Evaluation and Research (CBER), Food and Drug Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852-1448. Send one self-addressed adhesive label to assist the office in processing your requests. The guidance may also be obtained by mail by calling CBER at 1-800-835-4709 or 301-827-1800. See the SUPPLEMENTARY INFORMATION section for electronic access to the guidance document. ADDRESSES: Submit written comments on the guidance to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to *http://www.regulations.gov* . FOR FURTHER INFORMATION CONTACT: Denise Sánchez, Center for Biologics Evaluation and Research (HFM-17), Food and Drug Administration, 1401 Rockville Pike, suite 200N, Rockville, MD 20852-1448, 301-827-6210. SUPPLEMENTARY INFORMATION: I. Background FDA is announcing the availability of a document entitled “Guidance for Industry: Safety, Efficacy, and Pharmacokinetic Studies to Support Marketing of Immune Globulin Intravenous (Human) as Replacement Therapy for Primary Humoral Immunodeficiency,” dated June 2008. This guidance provides investigational new drug application
(IND)and biologics license application
(BLA)sponsors with recommendations for the design of clinical trials to assess the safety, efficacy, and pharmacokinetics of investigational IGIV products when used as replacement therapy in primary humoral immunodeficiency. This guidance is intended to assist sponsors in the preparation of the clinical/biostatistical and human pharmacokinetic sections of a BLA. This guidance does not address additional sections of a BLA, such as chemistry, manufacturing, and controls and pre-clinical toxicology, for an IGIV product for this indication. In the **Federal Register** of December 1, 2005 (70 FR 72124), FDA announced the availability of the draft guidance of the same title dated November 2005. FDA received several comments on the draft guidance and those comments were considered as the guidance was finalized. A summary of changes includes: Recommendations for compliance with the Pediatric Research Equity Act of 2007, refinements to the criteria for diagnosing serious infections, refinements to the recommended safety analyses of adverse experiences temporally related to infusions, and additional guidance on the methodology of pharmacokinetic studies. The guidance announced in this notice finalizes the draft guidance dated November 2005. The guidance is being issued consistent with FDA's good guidance practices regulation (21 CFR 10.115). The guidance represents FDA's current thinking on this topic. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statutes and regulations. II. Paperwork Reduction Act of 1995 This guidance refers to previously approved collections of information found in FDA regulations. These collections of information are subject to review by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The collections of information regarding BLAs (21 CFR part 601) have been approved under OMB control number 0910-0338. III. Comments Interested persons may, at any time, submit to the Division of Dockets Management (see ADDRESSES ) written or electronic comments regarding the guidance. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. A copy of the guidance and received comments are available for public examination in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Please note that on January 15, 2008, the FDA Division of Dockets Management Web site transitioned to the Federal Dockets Management System (FDMS). FDMS is a Government-wide, electronic docket management system. Electronic comments or submissions will be accepted by FDA only through FDMS at *http://www.regulations.gov* . IV. Electronic Access Persons with access to the Internet may obtain the guidance at either *http://www.fda.gov/cber/guidelines.htm* or *http://www.regulations.gov* . Dated: July 11, 2008. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E8-16395 Filed 7-16-08; 8:45 am] BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2003-D-0434] (formerly Docket No. 2003D-0420) Medical Devices: Radiology Devices; Class II Special Controls Guidance Document: Bone Sonometers; Guidance for Industry and Food and Drug Administration Staff AGENCY: Food and Drug Administration, HHS. ACTION: Notice of availability. SUMMARY: The Food and Drug Administration
(FDA)is announcing the availability of the guidance entitled “Guidance for Industry and FDA Staff; Class II Special Controls Guidance Document: Bone Sonometers.” The guidance document describes a means by which bone sonometers may comply with the requirement of special controls for class II devices. Elsewhere in this issue of the **Federal Register** , FDA is publishing a final rule reclassifying these devices from class III (premarket approval) into class II (special controls). DATES: Submit written or electronic comments on this guidance at any time. General comments on agency guidance documents are welcome at any time. ADDRESSES: Submit written requests for single copies of the guidance document entitled “Guidance for Industry and FDA Staff; Class II Special Controls Guidance Document: Bone Sonometers” to the Division of Small Manufacturers, International, and Consumer Assistance (HFZ-220), Center for Devices and Radiological Health, Food and Drug Administration, 1350 Piccard Dr., Rockville, MD 20850. Send one self-addressed adhesive label to assist that office in processing your request, or fax your request to 240-276-3151. See the SUPPLEMENTARY INFORMATION section for information on electronic access to the guidance. Submit written comments concerning this guidance to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments to *http://www.regulations.gov* . Identify comments with the docket number found in brackets in the heading of this document. FOR FURTHER INFORMATION CONTACT: Robert A. Phillips, Center for Devices and Radiological Health (HFZ-470), Food and Drug Administration, 9200 Corporate Blvd., Rockville, MD 20850, 240-276-3666. SUPPLEMENTARY INFORMATION: I. Background In the **Federal Register** of February 15, 2006 (71 FR 7894), FDA's Center for Devices and Radiological Health
(CDRH)published a proposed rule to reclassify bone sonometers from class III (premarket approval) into class II (special controls) after reviewing current technological and scientific developments. Specifically, CDRH reviewed recent studies addressing performance characteristics of bone sonometers manufactured by different companies and determined that, when combined with mitigation measures to offset the risks of use associated with these devices, special controls would be adequate to assure the safety and effectiveness of bone sonometers. To support the reclassification, CDRH issued a draft class II special controls guidance document entitled “Draft Guidance for Industry and FDA Staff; Class II Special Controls Guidance Document: Bone Sonometers” (71 FR 7976). Interested persons were invited to comment on the proposed rule and guidance by May 16, 2006, and the agency received three comments. The comments FDA received were supportive of the proposed reclassification, but made specific suggestions on the guidance's content. The agency considered the suggestions and made appropriate revisions. FDA is now identifying the guidance document entitled “Guidance for Industry and FDA Staff: Class II Special Controls Guidance Document: Bone Sonometers” as the guidance document that will serve as the special control for these devices. The guidance document provides a means by which bone sonometers may comply with the requirement of special controls for class II devices. Following the effective date of the final reclassification rule, any firm submitting a premarket notification under section 510(k) of the act (21 U.S.C. 360(k)) for bone sonometers will need to address the issues covered in the special controls guidance document. However, the firm need only show that its device meets the recommendation of the guidance document or in some other way provides equivalent assurances of safety and effectiveness. II. Significance of the Guidance This guidance is being issued consistent with FDA's good guidance practices regulation (21 CFR 10.115). The guidance represents the agency's current thinking on bone sonometers. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statute and regulations. III. Electronic Access Persons interested in obtaining a copy of the guidance may do so by using the Internet. To receive “Guidance for Industry and FDA Staff; Class II Special Controls Guidance Document: Bone Sonometers,” you may either send an e-mail request to *dsmica@fda.hhs.gov* to receive an electronic copy of the document or send a fax request to 240-276-3151 to receive a hard copy. Please use the document number
(1547)to identify the guidance you are requesting. CDRH maintains an entry on the Internet for easy access to information including text, graphics, and files that may be downloaded to a personal computer with Internet access. Updated on a regular basis, the CDRH home page includes device safety alerts, **Federal Register** reprints, information on premarket submissions (including lists of approved applications and manufacturers' addresses), small manufacturer's assistance, information on video conferencing and electronic submissions, Mammography Matters, and other device-oriented information. The CDRH Web site may be accessed at *http://www.fda.gov/cdrh* . A search capability for all CDRH guidance documents is available at *http://www.fda.gov/cdrh/guidance.html* . Guidance documents are also available at *http://www.regulations.gov* . IV. Paperwork Reduction Act of 1995 This guidance refers to previously approved collections of information found in FDA regulations. These collections of information are subject to review by the Office of Management and Budget
(OMB)under the Paperwork Reduction Act of 1995 (44 U.S.C. 3501-3520). The collections of information in 21 CFR part 56 have been approved under OMB control number 0910-0130; the collections of information in 21 CFR part 801 have been approved under OMB control number 0910-0485; the collections of information in 21 CFR part 807, subpart E, have been approved under OMB control number 0910-0120; the collections of information in 21 CFR part 812 have been approved under OMB control number 0910-0078; the information collections in 21 CFR part 820 have been approved under OMB control number 0910-0073; and the information collections in 21 CFR parts 1002, 1003, and 1004 have been approved under OMB control number 0910-0025. V. Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES ) written or electronic comments regarding this document. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. Received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Please note that on January 15, 2008, the FDA Division of Dockets Management Web site transitioned to the Federal Dockets Management System (FDMS). FDMS is a Government-wide, electronic docket management system. Electronic comments or submissions will be accepted by FDA only through FDMS at *http://www.regulations.gov* . Dated: July 2, 2008. Daniel G. Schultz, Director, Center for Devices and Radiological Health. [FR Doc. E8-16094 Filed 7-16-08; 8:45 am] BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-1995-N-0054] (formerly Docket No. 1995N-0304) Small Entity Compliance Guide: Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is announcing the availability of a small entity compliance guide
(SECG)for a final rule published in the **Federal Register** of February 11, 2004 (69 FR 6788), entitled “Final Rule Declaring Dietary Supplements Containing Ephedrine Alkaloids Adulterated Because They Present an Unreasonable Risk.” This SECG is intended to set forth in plain language the requirements of the regulation and to help small businesses understand the regulation. DATES: Submit written or electronic comments on the SECG at any time. ADDRESSES: Submit written comments on the SECG to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments on the SECG to *http://www.regulations.gov* . Submit written requests for single copies of the SECG to the Division of Dietary Supplement Programs, Office of Nutrition, Labeling, and Dietary Supplements (HFS-810), Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, or fax your request to 301-436-2639. Send one self-addressed adhesive label to assist that office in processing your request. See the SUPPLEMENTARY INFORMATION section for electronic access to the SECG. FOR FURTHER INFORMATION CONTACT: Robert J. Moore, Center for Food Safety and Applied Nutrition (HFS-810), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301-436-2375. SUPPLEMENTARY INFORMATION: I. Background In the **Federal Register** of February 11, 2004, FDA issued a final rule declaring dietary supplements containing ephedrine alkaloids adulterated under the Federal Food, Drug, and Cosmetic Act because they present an unreasonable risk of illness or injury under the conditions of use recommended or suggested in labeling, or if no conditions of use are suggested or recommended in labeling, under ordinary conditions of use. This final rule became effective April 12, 2004. FDA examined the economic implementation of the final rule as required by the Regulatory Flexibility Act (5 U.S.C. 601-602) and determined that the final rule would have a significant economic impact on a substantial number of small entities. In compliance with section 212 of the Small Business Regulatory Enforcement Fairness Act (Public Law 104-121), FDA is making available this SECG stating in plain language the requirements of the regulation. FDA is issuing this SECG as a level 2 guidance consistent with FDA's good guidance practices regulation (21 CFR 10.115(c)(2)). The SECG represents the agency's current thinking on this subject. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statutes and regulations. II. Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES ) written or electronic comments regarding this SECG. Submit a single copy of electronic comments or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. The SECG and received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Please note that on January 15, 2008, the FDA Division of Dockets Management Web site transitioned to the Federal Dockets Management System (FDMS). FDMS is a Government-wide, electronic docket management system. Electronic comments or submissions will be accepted by FDA only through FDMS at *http://www.regulations.gov* . III. Electronic Access Persons with access to the Internet may obtain the document at *http://www.cfsan.fda.gov/guidance.html* . Dated: July 10, 2008. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E8-16396 Filed 7-16-08; 8:45 am] BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Food and Drug Administration [Docket No. FDA-2008-N-0361] Small Entity Compliance Guide: Standard of Identity for White Chocolate; Availability AGENCY: Food and Drug Administration, HHS. ACTION: Notice. SUMMARY: The Food and Drug Administration
(FDA)is announcing the availability of a small entity compliance guide
(SECG)for a final rule published in the **Federal Register** of October 4, 2002 (67 FR 62171). This SECG entitled “Standard of Identity for White Chocolate” is intended to set forth, in plain language, the requirements of the regulation and to help small businesses understand the regulation. DATES: Submit written or electronic comments on the SECG at any time. ADDRESSES: Submit written comments on the SECG to the Division of Dockets Management (HFA-305), Food and Drug Administration, 5630 Fishers Lane, rm. 1061, Rockville, MD 20852. Submit electronic comments on the SECG to *http://www.regulations.gov* . Submit written requests for single copies of the SECG to the Office of Nutrition, Labeling, and Dietary Supplements (HFS-800), Center for Food Safety and Applied Nutrition, Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740. Send one self-addressed adhesive label to assist that office in processing your requests. See the SUPPLEMENTARY INFORMATION section for electronic access to the SECG. FOR FURTHER INFORMATION CONTACT: Geraldine June, Center for Food Safety and Applied Nutrition (HFS-820), Food and Drug Administration, 5100 Paint Branch Pkwy., College Park, MD 20740, 301-436-2371. SUPPLEMENTARY INFORMATION: I. Background In the **Federal Register** of October 4, 2002, FDA issued a final rule establishing a standard of identity for white chocolate. That final rule became effective January 1, 2004. FDA examined the economic implementation of the final rule as required by the Regulatory Flexibility Act (5 U.S.C. 601-602) and determined that the final rule would have a significant economic impact on a substantial number of small entities. In compliance with section 212 of the Small Business Regulatory Enforcement Fairness Act (Public Law 104-121), FDA is making this SECG available by stating, in plain language, the requirements of the regulation. FDA is issuing this SECG as level 2 guidance consistent with FDA's good guidance practices regulation (21 CFR 10.115(c)(2)). The SECG represents the agency's current thinking on this subject. It does not create or confer any rights for or on any person and does not operate to bind FDA or the public. An alternative approach may be used if such approach satisfies the requirements of the applicable statutes and regulations. II. Comments Interested persons may submit to the Division of Dockets Management (see ADDRESSES ) written or electronic comments regarding this SECG. Submit a single copy of electronic comments to or two paper copies of any mailed comments, except that individuals may submit one paper copy. Comments are to be identified with the docket number found in brackets in the heading of this document. The SECG and received comments may be seen in the Division of Dockets Management between 9 a.m. and 4 p.m., Monday through Friday. Please note that on January 15, 2008, the FDA Division of Dockets Management Web site transitioned to the Federal Dockets Management System (FDMS). FDMS is a Government-wide, electronic docket management system. Electronic comments or submissions will be accepted by FDA only through FDMS at *http://www.regulations.gov* . III. Electronic Access Persons with access to the Internet may obtain the document at *http://www.cfsan.fda.gov/guidance.html* . Dated: July 10, 2008. Jeffrey Shuren, Associate Commissioner for Policy and Planning. [FR Doc. E8-16394 Filed 7-16-08; 8:45 am] BILLING CODE 4160-01-S DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Agency Information Collection Activities: Submission for OMB Review; Comment Request Periodically, the Health Resources and Services Administration
(HRSA)publishes abstracts of information collection requests under review by the Office of Management and Budget (OMB), in compliance with the Paperwork Reduction Act of 1995 (44 U.S.C. Chapter 35). To request a copy of the clearance requests submitted to OMB for review, e-mail *paperwork@hrsa.gov* or call the HRSA Reports Clearance Office on (301)-443-1129. The following request has been submitted to the Office of Management and Budget for review under the Paperwork Reduction Act of 1995: Proposed Project Health Education Assistance Loan
(HEAL)Program: Lender's Application for Insurance Claim Form and Request for Collection Assistance Form (OMB No. 0915-0036)—Extension The HEAL program assures the availability of funds for loans to eligible students who desire to borrow money to pay for their educational costs. HEAL Lenders use the Lenders Application for Insurance Claim to request payment from the Federal Government for federally insured loans lost due to borrowers' death, disability, bankruptcy, or default. The Request for Collection Assistance form issued by HEAL lenders to request federal assistance with the collection of delinquent payments from HEAL borrowers. The burden estimates are as follows: Form Number of respondents Responses per respondent Total responses Hours per response Total burden hours Lender's Application for Insurance Claim 17 25 425 .5 213 Request for Collection Assistance 17 550 9,350 .167 1,561 Total 17 9,775 1,774 Written comments and recommendations concerning the proposed information collection should be sent within 30 days of this notice to the desk officer for HRSA, either by e-mail to *OIRA_submission@omb.eop.gov* or by fax to 202-395-6974. Please direct all correspondence to the “attention of the desk officer for HRSA.” Dated: July 8, 2008. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E8-16358 Filed 7-16-08; 8:45 am] BILLING CODE 4165-15-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Health Resources and Services Administration Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children (ACHDGDNC); Notice of Meeting In accordance with section 10(a)(2) of the Federal Advisory Committee Act (Pub. L. 92-463), notice is hereby given of the following meeting: *Name:* Advisory Committee on Heritable Disorders and Genetic Diseases in Newborns and Children. *Date and Time:* August 7, 2008, 1 p.m.-5 p.m., EDT. *Place:* Audio Conference Call. The ACHDNC will meet on Thursday, August 7, from 1 p.m. to 5 p.m., (EDT). The public can join the meeting via conference call by dialing 1-(866) 245-0358 on August 7 and providing the following information: *Leader's Name:* Carrie Diener. *Project Code:* 10596001001. *Pass Code:* 496966. Participants should call no later than 12:30 p.m. EDT in order for the logistics to be established for participation in the call. Participants also are asked to register for the conference by going to the registration Web site at *http://www.signup4.net/public/ap.aspx?EID=ADVI12E&OID=130.* The registration deadline is Wednesday, August 6, 2008. If there are technical problems gaining access to the call, please contact Tamar R. Shealy, Meetings Manager, Conference and Meetings Management, Altarum Institute, telephone:
(202)828-5100. *Agenda:* The agenda will include discussion on the ACHDGDNC's evidence review process and to hear discussion from the ACHDGDNC members on condition nomination packages submitted for review by the ACHDGDNC for inclusion on the uniform newborn screening panel. Agenda items are subject to change as priorities dictate. You can also locate the Agenda, presentations and meeting materials at the home page of the Web site at *http://www.signup4.net/public/ap.aspx?EID=ADVI12E&OID=50.* *Public Comments:* Members of the public can present oral comments during the public comment period of the conference call. Those individuals are required to register online by Wednesday, August 6, 2008, at *http://www.signup4.net/public/ap.aspx?EID=ADVI12E&OID=130.* Requests will contain the name, address, telephone number, and any professional or business affiliation of the person desiring to make an oral presentation. Groups having similar interests are requested to combine their comments and present them through a single representative. The allocation of time may be adjusted to accommodate the level of expressed interest. Each public commentator will be notified by email of their assigned presentation time. Members of the public are required to submit written comments that will be distributed to Committee members prior to the conference call. Parties wishing to submit written comments should ensure that the comments are postmarked or emailed no later than July 31, 2008, for consideration. Comments should be submitted to Tamar R. Shealy, Meetings Manager, Conference and Meetings Management, Altarum Institute, 1200 18th Street, NW., Suite 700, Washington, DC 20036, telephone:
(202)828-5100; fax:
(202)785-3083, or e-mail: *Tamar.Shealy@altarum.org.* *For Further Information Contact:* Anyone requiring information regarding the ACHDNC should contact : Jill F. Shuger, M.S., Maternal and Child Health Bureau, HRSA, Parklawn Building, Room 18A-19, 5600 Fishers Lane, Rockville, Maryland 20857; telephone
(301)443-1080; fax
(301)594-0878; or e-mail: *jshuger@hrsa.gov.* *Supplementary Information:* The ACHDNC was chartered originally under Section 1111 of the Public Health Service
(PHS)Act, 42 U.S.C. 300b-10 in February 2003 to advise the Secretary of the U.S. Department of Health and Human Services and as amended in the Newborn Screening Saves Lives Act. The Committee is governed by the provisions of Public Law 92-463, as amended (5 U.S.C. App. 2), and 41 CFR part 102-3, which sets forth standards for the formation and use of advisory committees. The ACHDNC is directed to review and report regularly on newborn and childhood screening practices for heritable disorders and to recommend improvements in the national newborn and childhood heritable screening programs. Dated: July 9, 2008. Alexandra Huttinger, Director, Division of Policy Review and Coordination. [FR Doc. E8-16360 Filed 7-16-08; 8:45 am] BILLING CODE 4165-15-P DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Office of Urban Indian Health Programs *Announcement Type:* Competitive Targeted Solicitation. *Funding Opportunity Number:* HHS-2008-IHS-UIHP-0002. *Catalog of Federal Domestic Assistance Number:* 93.193. *Key Dates: Application Deadline Date:* August 8, 2008. *Review Date:* August 11, 2008. *Earliest Anticipated Start Date:* September 1, 2008. I. Funding Opportunity Description The Indian Health Service (IHS), Office of Urban Indian Health Programs (OUIHP) announces an open competition for the 4-in-1 Title V grants responding to an Office of Minority Health, human immunodeficiency virus/acquired immunodeficiency syndrome (HIV/AIDS) Initiative. This program is authorized under the authority of the Snyder Act and 25 U.S.C. 1652, 1653 of the Indian Health Care Improvement Act, Public Law 94-437, as amended. This program is described at 93.193 in the Catalog of Federal Domestic Assistance (CFDA). This open competition seeks to expand OUIHP's existing Title V grants to increase the number of American Indian/Alaska Natives (AI/AN) with awareness of his/her HIV status. This will provide routine and/or rapid HIV screening, prevention, pre and post test counseling (when appropriate), and data collection. Enhancement of urban Indian health program HIV/AIDS activities is necessary to reduce the incidence of HIV/AIDS in the urban Indian health communities. The purpose of the announcement is to respond to the fact that communities of color have been disproportionately affected by HIV and the need exists for access to early testing, diagnosis, treatment and prevention services. Over the past decade, the AI/AN community has developed and maintained a higher rate of HIV than Caucasians. It has also been demonstrated that AI/ANs have a decreased longevity once diagnosed compared to other races/ethnicities. These supplements will be used to enhance HIV testing, including rapid testing and/or standard HIV antibody testing and to provide a more focused effort to address HIV/AIDS prevention, targeting some of the largest urban Indian populations in the United States. *The nature of these projects will require collaboration with the OUIHP to:*
(1)Coordinate activities;
(2)participate in projects in other operating divisions of the Department of Health and Human Services
(HHS)such as the Centers for Disease Control and Prevention, Substance Abuse and Mental Health Services Administration, Health Resource and Services Administration and the Office of HIV/AIDS Policy; and
(3)submit and share data on HIV/AIDS testing, treatment and education. II. Award Information *Type of Award:* Title V Grant Supplements. *Estimated Funds Available:* The total amount identified for Fiscal Year
(FY)2008 is fourteen awards totaling $350,000. The award is for one year in duration and the average award, per program is approximately $25,000. Awards under this announcement are subject to the availability of funds. *Anticipated Number of Awards:* Fourteen grant awards will be made under the Program. *Project Period:* September 1, 2008-August 31, 2009. *Award Amount:* $350,000. A. Requirements of Recipient Activities In FY 2008 each grantee's attempted goal shall include screening as many individuals as possible; however, increasing screening 10% or to a minimum of 200 American Indians/Alaska Natives (AI/AN) tested per program funded adjusted due to variations in size of facility and user population may be required. This does not include counts of re-testing individuals in the same year. Each program shall also collect evidence, as part of the testing process, to potentially address utility and barriers of increased routine HIV screening within this population. III. Eligibility Information 1. *Eligible Applicants:* Urban Indian organizations, as defined by 25 U.S.C. 1603(h), limited to urban Indian organizations which meet the following criteria: a. Received State certification to conduct HIV rapid testing; b. Health professionals and staff have been trained in the HIV/AIDS screening tools, education, prevention, counseling, and other interventions for AI/ANs; c. Attuned to the risk factors driving the HIV/AIDS epidemics among urban AI/ANs; d. Developed programs to address community and group support to sustain risk reduction skills; e. Implemented HIV/AIDS quality assurance and improvement programs; and f. Must provide proof of non-profit status with the application. 2. *Cost Sharing or Matching* —This program does not require matching funds or cost sharing. 3. If the application budget exceeds $25,000 it will not be considered for review. IV. Application and Submission Information 1. *Applicant package may be found in Grants.gov* ( *www.grants.gov* ) or at: *http://www.ihs.gov/NonMedicalPrograms/gogp/gogp_funding.asp* . Questions regarding the electronic application process may be directed to Michelle G. Bulls at
(301)443-6290. 2. *Content and Form of Application Submission:* • Be single spaced. • Be typewritten. • Have consecutively numbered pages. • Use black type not smaller than 12 characters per one inch. • Contain a narrative that does not exceed 25 typed pages that includes the other submission requirements below. The 25 page narrative does not include the work plan, standard forms, table of contents, budget, budget justifications, narratives, and/or other appendix items. *Public Policy Requirements:* All Federal-wide public policies apply to IHS grants with the exception of Lobbying and Discrimination public policy. 3. *Submission Dates and Times:* The application from each urban Indian organization must be submitted electronically through Grants.gov by 12 midnight Eastern Standard Time (EST). If technical challenges arise and the urban Indian organizations are unable to successfully complete the electronic application process, each organization must contact Michelle G. Bulls, Grants Policy Staff
(GPS)fifteen days prior to the application deadline and advise of the difficulties that they are experiencing. Each organization must obtain prior approval, in writing (e-mails are acceptable), from Ms. Bulls allowing the paper submission. If submission of a paper application is requested and approved, the original and two copies may be sent to the appropriate grants contact that is listed in Section IV.1 above. Applications not submitted through Grants.gov, without an approved waiver, may be returned to the organizations without review or consideration. A late application will be returned to the organization without review or consideration. 4. *Intergovernmental Review:* Executive Order 12372 requiring intergovernmental review is not applicable to this program. 5. *Funding Restrictions:* A. Pre-award costs are allowable pending prior approval from the awarding agency. However, in accordance with 45 CFR part 74, all pre-award costs are incurred at the recipient's risk. The awarding office is under no obligation to reimburse such costs if for any reason any of the urban Indian organizations do not receive an award or if the award to the recipient is less than anticipated. B. The available funds are inclusive of direct and appropriate indirect costs. C. Only one grant supplement will be awarded to each organization. D. IHS will acknowledge receipt of the application. 6. *Other Submission Requirements:* *Electronic Submission* —Each urban Indian organization must submit through Grants.gov. However, should any technical challenges arise regarding the submission, please contact Grants.gov. Customer Support at 1-800-518-4726 or *support@grants.gov* . The Contact Center hours of Operation are Monday-Friday from 7 a.m. to 9 p.m. EST. If you require additional assistance please call
(301)443-6290 and identify the need for assistance regarding your Grants.gov application. Your call will be transferred to the appropriate grants staff member. Each organization must seek assistance at least fifteen days prior to the application deadline. If each organization doesn't adhere to the timelines for Central Contractor Registry (CCR), Grants.gov registration and request timely assistance with technical issues, paper application submission may not be granted. To submit an application electronically, please use the Grants.gov Web site. Download a copy of the application package on the Grants.gov Web site, complete it offline and then upload and submit the application via the Grants.gov site. You may not e-mail an electronic copy of a grant application to IHS. *Please be reminded of the following:* • Under the new IHS application submission requirements, paper applications are not the preferred method. However, if any urban Indian organization has technical problems submitting the application on-line, please contact directly Grants.gov Customer Support at: *http://www.grants.gov/CustomerSupport* . • Upon contacting Grants.gov, obtain a Grants.gov tracking number as proof of contact. The tracking number is helpful if there are technical issues that cannot be resolved and a waiver request from Grants Policy must be obtained. If any of the organizations are still unable to successfully submit the application on-line, please contact Michelle G. Bulls, GPS at
(301)443-6290 at least fifteen days prior to the application deadline to advise her of the difficulties you have experienced. • If it is determined that a formal waiver is necessary, each organization must submit a request, in writing (e-mails are acceptable), to *Michelle.Bulls@ihs.gov* providing a justification for the need to deviate from the standard electronic submission process. Upon receipt of approval, a hard copy application package must be downloaded from Grants.gov, and sent directly to the Division of Grants Operations (DGO), 801 Thompson Avenue, TMP 360, Rockville, MD 20852 by August 8, 2008. • Upon entering the Grants.gov Web site, there is information available that outlines the requirements to each urban Indian organization regarding electronic submission of application and hours of operation. We strongly encourage that each organization does not wait until the deadline date to begin the application process as the registration process for CCR and Grants.gov could take up to fifteen working days. • To use Grants.gov, each urban Indian organization must have a Data Universal Numbering System
(DUNS)Number and register in the CCR. Each organization should allow a minimum of ten working days to complete CCR registration. See below on how to apply. • Each organization must submit all documents electronically, including all information typically included on the SF-424 and all necessary assurances and certifications. • Please use the optional attachment feature in Grants.gov to attach additional documentation that may be requested by IHS. • Each organization must comply with any page limitation requirements described in the program announcement. • After you electronically submit your application, you will receive an automatic acknowledgment from Grants.gov that contains a Grants.gov tracking number. The DGO will retrieve your application from Grants.gov. The DGO will notify each organization that the application has been received. • You may access the electronic application for this program on Grants.gov. • You may search for the downloadable application package using either the CFDA number or the Funding Opportunity Number. Both numbers are identified in the heading of this announcement. • To receive an application package, each urban Indian organization must provide the Funding Opportunity Number: HHS-2008-IHS-UIHP-0002. E-mail applications will not be accepted under this announcement. DUNS Number Applicants are required to have a DUNS number to apply for a grant or cooperative agreement from the Federal Government. The DUNS number is a nine-digit identification number, which uniquely identifies business entities. Obtaining a DUNS number is easy and there is no charge. To obtain a DUNS number, access *http://www.dunandbradstreet.com* or call 1-866-705-5711. Interested parties may wish to obtain their DUNS number by phone to expedite the process. Applications submitted electronically must also be registered with the CCR. A DUNS number is required before CCR registration can be completed. Many organizations may already have a DUNS number. Please use the number listed above to investigate whether or not your organization has a DUNS number. Registration with the CCR is free of charge. Applicants may register by calling 1-888-227-2423. Please review and complete the CCR “Registration Worksheet” located on *http://www.ccr.gov* . More detailed information regarding these registration processes can be found at Grants.gov. V. Application Review Information 1. Criteria The instructions for preparing the application narrative also constitute the evaluation criteria for reviewing and scoring the application. Weights assigned to each section are noted in parentheses. The narrative should include the first year of activities; information for multi-year projects should be included as an appendix (see E. “Categorical Budget and Budget Justification”) at the end of this section for more information. The narrative should be written in a manner that is clear to outside reviewers unfamiliar with prior related activities of the urban Indian organization. It should be well organized, succinct, and contain all information necessary for reviewers to understand the project fully. A. Understanding of the Need and Necessary Capacity (30 Points) 1. Understanding of the Problem a. Define the project target population, identify their unique characteristics, and describe the impact of HIV on the population. b. Describe the gaps/barriers in HIV testing for the population. c. Describe the unique cultural or sociological barriers of the target population to adequate access for the described services. 2. Facility Capability a. Briefly describe your clinic programs and services and how this initiative complements and/or expands existing efforts. b. Describe your clinic's ability to conduct this initiative through: • Your clinic's own resources. • Collaboration with other providers. • Partnerships established to accept referrals for counseling, testing, and referral and confirmatory blood tests and/or social services for individuals who test HIV positive. • Partnerships established to refer out of your clinic for specialized treatment, care, confirmatory testing (if applicable) and counseling services. B. Work Plan (40 Points) 1. Project Goal and Objectives Address all of the following program goals and objectives of the project. The objectives must be specific as well as quantitatively and qualitatively measurable to ensure achievement of goal(s). • President's Initiative for HIV/AIDS Explain how the continuation program addresses the President's Initiative for HIV/AIDS objective requiring testing of those who do not know their status. For a more direct and relevant program initiative, this proposal will be enumerated in the development of the new IHS HIV/AIDS Strategic Plan. • HHS Strategic Plan Support Describe how implementing, expanding and making routine HIV/AIDS direct service opportunities in your clinic ensures an innovative approach towards achievement of two of the most critical HHS Strategic Plan Objectives relative to the health status of AI/AN: Objective 3.4—Eliminate racial and ethnic health disparities. Objective 3.6—Increase access to health services for AI/AN. • Office of the Secretary Minority AIDS Initiative Address how the Minority AIDS Initiative Goals/Objectives will be supported. If a goal/objective is not applicable to your program, explain why it is not applicable. Provide quantitative and qualitative objectives for each of the following. 1. Expand Services a. Increase the number of clients receiving services; b. Increase the number of clients that receive an HIV test and are provided results and know their status; and c. Increase the number of clients treated and/or referred into the system for medical care. 2. Build Capacity a. Identify the number of providers that have expanded their: • Knowledge of HIV screening methods; • Knowledge of streamlining procedures; and • Collaboration with outside entities such as CDC, HRSA, and/or State health departments. 3. Best Practices Models a. Identify best practice models of implementation of expanded services. 4. Enumerate lessons observed and address barriers to care. • IHS Strategic Plan Support Describe how this project integrates with the IRS Strategic Plan which includes concepts surrounding: 1. Building and sustaining healthy communities; 2. Providing accessible, quality health care; and 3. Fostering collaboration and innovation across the Indian health network. • IHS HIV/AIDS Administrative Work Plan Goals Describe how the IHS HIV/AIDS Administrative work plan goals will be supported. If a goal is not applicable to your program, explain why it is not applicable. 1. Assist AI/AN in becoming aware of serostatus; 2. Reduce the transmission of HIV through behavior change, prevention education and open discussion; 3. Ensure access (and linkages) to services for those living with HIV/AIDS and those at risk; 4. Provide routine HIV/AIDS services and ensure quality HIV/AIDS care is delivered within the Indian health system; 5. Reduce stigma and discrimination surrounding HIV/AIDS; and 6. Form sustainable collaborations and integrative approaches ( *i.e.* Sexually Transmitted Diseases and HIV integration) to build capacity and maximize resources for surveillance, prevention, treatment and mitigation. • Implementation Plan 1. Identify the proposed program activities and explain how these activities will meet the needs of the target population. 2. Describe any anticipated outcomes that may be achieved from this project plan. 3. Provide a timeline for implementation. 4. Certify that the program identified and agreed to follows the State regulations for HIV testing in their State. 5. Describe how individuals will be selected for testing to identify selection criteria and which group(s)—if any—will you be able, via State regulations to offer testing in an opt-out format. 6. Describe how the program will ensure that clients receive their test results, particularly clients who test positive. 7. Describe how the program will ensure that individuals with initial HIV-positive test results will receive confirmatory tests. If you do not provide confirmatory HIV testing, you must provide a letter of intent or Memorandum of Understanding with an external laboratory documenting the process through which initial HIV-positive test results will be confirmed. 8. Describe the program strategies to linking potential seropositive patients to care. 9. Describe the program quality assurance strategies. 10. Describe how the program will train, support and retain staff providing counseling and testing. 11. Describe how the program will ensure client confidentiality. 12. Describe how the program will ensure that your services are culturally sensitive and relevant. 13. Describe how the program will attempt to streamline procedures so as to reduce the overall cost per test administered. • Staffing Plan Describe the existing or proposed positions to be funded and provide names and roles of the key position(s) carrying out this project, their qualifications and how they relate to the organization, with regard to supervision and quality control. C. Project Evaluation (10 Points) 1. Evaluation Plan The grantee shall provide a plan for monitoring and evaluating the HIV rapid test and/or standard HIV antibody test. 2. Reporting Requirements The following quantitative and qualitative measures shall be addressed: • Indicators (Quantitative) 1. Number of tests offered and number of test refusals. 2. Number of clients who refused due to prior knowledge of status. 3. Number of individuals tested with breakdown of rapid versus standard antibody test. 4. Number of negative results. 5. Number of false negatives and/or false positives after confirmatory testing. 6. Number of reactive tests and confirmed seropositive (actual and proportion). 7. Number of individuals receiving their confirmatory test results. 8. Number of clients learning of their serostatus for the first time via this testing initiative. 9. Number of clients linked to care/treatment or referrals for prevention counseling. 10. Number of post-test counseling sessions. 11. Number of pre-test counseling sessions (brief). 12. Number of prevention counseling sessions (more depth) due to higher risk populations. 13. Number of missed follow up after rapid test is reactive. 14. Transmission category (if known). 15. Measures in place to protect confidentiality. • Qualitative Information 1. Identify Testing Methodology a. Will testing be rapid or standard? b. Opt-out format should be utilized. Unless otherwise determined by State regulations—please explain. c. Is your methodology based on risk-based screening? Based on what risk criteria? Are you offering more routine screening? What are the criteria for offering tests if any? 2. Identify barriers of implementation • Plan for obtaining knowledge, attitudes, and behavior data. D. Organizational Capabilities and Qualifications (10 Points) This section outlines the broader capacity of the organization to complete the project outlined in the work plan. It includes the identification of personnel responsible for completing tasks and the chain of responsibility for successful completion of the project outlined in the work plan. 1. Describe the organizational structure. 2. Describe the ability of the organization to manage the proposed project. Include information regarding similarly sized projects in scope and financial assistance as well as other grants and projects successfully completed. 3. Describe what equipment ( *i.e.* , phone, Web sites, etc.) and facility space ( *i.e.* , office space) will be available for use during the proposed project. Include information about any equipment not currently available that will be purchased throughout the agreement. 4. List key personnel who will work on the project. • Identify existing personnel and new program staff to be hired. • In the appendix, include position descriptions and resumes for all key personnel. Position descriptions should clearly describe each position and duties indicating desired qualifications, experience, and requirements related to the proposed project and how they will be supervised. Resumes must indicate that the proposed staff member is qualified to carry out the proposed project activities and who will determine if the work of a contractor is acceptable. • Note who will be writing the progress reports. • If a position is to be filled, indicate that information on the proposed position description. • If the project requires additional personnel beyond those covered by the supplemental grant ( *i.e.* , IT support, volunteers, interviewers, etc.), note these and address how these positions will be filled and, if funds are required, and the source of these funds. • If personnel are to be only partially funded by this supplemental grant, indicate the percentage of time to be allocated to this project and identify the resources used to fund the remainder of the individual's salary. E. Categorical Budget and Budget Justification (10 Points) This section should provide a clear estimate of the project program costs and justification for expenses for the entire grant period. The budget and budget justification should be consistent with the tasks identified in the work plan. 1. Categorical budget (Form SF 424A, Budget Information Non-Construction Programs) completing each of the budget periods requested. 2. Narrative justification for all costs, explaining why each line item is necessary or relevant to the proposed project. Include sufficient details to facilitate the determination of cost allowability. 3. Budget justification should include a brief program narrative for the second and third years. 4. If indirect costs are claimed, indicate and apply the current negotiated rate to the budget. Include a copy of the rate agreement in the appendix. 2. Review and Selection Process *In addition to the above criteria/requirements, the application will be considered according to the following:* A. *The submission deadline:* August 8, 2008. The application submitted in advance of or by the deadline and verified by the postmark will undergo a preliminary review to determine that: • The applicant is eligible in accordance with this grant announcement. • The application is not a duplication of a previously funded project. • The application narrative, forms, and materials submitted meet the requirements of the announcement allowing the review panel to undertake an in-depth evaluation; otherwise, it may be returned. B. The Objective Review date is August 11, 2008. The application requirements that are complete, responsive, and conform to this program announcement will be reviewed for merit by the Ad Hoc Objective Review Committee
(ORC)appointed by the IHS to review and make recommendations on this application. Prior to ORC review, the application will be screened to determine that programs proposed are those which the IHS has the authority to provide, either directly or through funding agreement, and that those programs are designed for the benefit of IHS beneficiaries. If an urban Indian organization does not meet these requirements, the application will not be reviewed. The ORC review will be conducted in accordance with the IHS Objective Review Guidelines. The application will be evaluated and rated on the basis of the evaluation criteria listed in section V.1. The criteria are used to evaluate the quality of a proposed project and determine the likelihood of success. 3. Anticipated Announcement and Award Dates Anticipated announcement date is August 8, 2008 with an Award Date of September 1, 2008. VI. Award Administration Information 1. Award Notices The Notice of Award
(NoA)will be initiated by the DGO and will be mailed via postal mail to the urban Indian organization. The NoA will be signed by the Grants Management Officer and this is the authorizing document under which funds are dispersed. The NoA, is the legally binding document, will serve as the official notification of the grant award and will reflect the amount of Federal funds awarded for the purpose of the grant, the terms and conditions of the award, the effective date of the award, and the budget/project period. 2. Administrative Requirements *Grants are administered in accordance with the following documents:* • This Program Announcement. • 45 CFR part 74, “Uniform Administrative Requirements for Awards to Institutions of Higher Education, Hospitals, Other Non-Profit Organizations, and Commercial Organizations.” • Grants Policy Guidance: HHS Grants Policy Statement, January 2007. • “Non-Profit Organizations” (Title 2 part 230). • *Audit Requirements:* OMB Circular A-133, “Audits of States, Local Governments, and Non-Profit Organizations.” 3. *Indirect Costs:* This section applies to indirect costs in accordance with HHS Grants Policy Statement, Part 11-27. The IHS requires applicants to have a current indirect cost rate agreement in place prior to award. The rate agreement must be prepared in accordance with the applicable cost principles and guidance as provided by the cognizant agency or office. A current rate means the rate covering the applicable activities and the award budget period. If the current rate is not on file with the awarding office, the award shall include funds for reimbursement of indirect costs. However, the indirect costs portion will remain restricted until the current rate is provided to the DGO. If an urban Indian organization has questions regarding the indirect costs policy, please contact the DGO at
(301)443-5204. 4. Reporting A. *Progress Report.* Program progress reports are required semi-annually. These reports will include a brief comparison of actual accomplishments to the goals established for the period, reasons for slippage (if applicable), and other pertinent information as required. A final report must be submitted within 90 days of expiration of the budget/project period. B. *Financial Status Report.* Semi-annual financial status reports must be submitted within 30 days of the end of the half year. Final financial status reports are due within 90 days of expiration of the budget period. Standard Form 269 (long form) will be used for financial reporting. Failure to submit required reports within the time allowed may result in suspension or termination of an active agreement, withholding of additional awards for the project, or other enforcement actions such as withholding of payments or converting to the reimbursement method of payment. Continued failure to submit required reports may result in one or both of the following:
(1)The imposition of special award provisions; and
(2)the non-funding or non-award of other eligible projects or activities. This applies whether the delinquency is attributable to the failure of the organization or the individual responsible for preparation of the reports. Telecommunication for the hearing impaired is available at: TTY 301-443-6394. VII. Agency Contacts For program-related and general information regarding this announcement: Danielle Steward, Health Systems Specialist, Office of Urban Indian Health Programs, 801 Thompson Avenue, Room 200, Rockville, MD 20852,
(301)443-4680 or *danielle.steward@ihs.gov* . *For specific grant-related and business management information:* Denise Clark, Senior Grants Management Specialist, 801 Thompson Avenue, TMP 360, Rockville, MD 20852, 301-443-5204 or *denise.clark@ihs.gov* . Dated: July 8, 2008. Robert G. McSwain, Director, Indian Health Service. [FR Doc. E8-16051 Filed 7-16-08; 8:45 am] BILLING CODE 4165-16-M DEPARTMENT OF HEALTH AND HUMAN SERVICES Indian Health Service Organization, Functions, and Delegations of Authority, Part G, Indian Health Service, Proposed Functional Statement Office of Information Technology
(1)Provides Chief Information Officer
(CIO)services and advises the Director, Indian Health Service (IHS), on all aspects of information resource management and technology;
(2)ensures Agency compliance with related Federal laws, regulations, and policies;
(3)directs the development, implementation, and maintenance of policies, procedures, standards, and architecture for information resource management, technology activities, and services in the IHS;
(4)directs strategic planning and budgeting processes for information resources and technology;
(5)leads IHS efforts in developing and implementing information resource and technology management initiatives in IHS;
(6)directs the design, development, acquisition, implementation, and support of robust information systems and services used in the IHS;
(7)directs the activities of the IHS Information Technology Investment Review Board (ITIRB) in assessing, implementing, and reviewing the Agency's information systems;
(8)contracts for information resource and technology-related software, equipment, and support services in collaboration with appropriate acquisition authorities;
(9)provides project management support for information resource and technology initiatives;
(10)directs the development, implementation, and management of the IHS Information Technology Security program to protect the information resources of the IHS;
(11)provides information technology
(IT)services and support to IHS, Tribal, and Urban Indian Health Programs (UIHP), including the Resource and Patient Management System (RPMS), Electronic Health Record (EHR), and the National Patient Information Reporting System (NPIRS);
(12)ensures accessibility to IT services;
(13)represents the IHS and enters into IT agreements with Federal, Tribal, State and other organizations; and
(14)participates in cross-cutting issues and processes including, but not limited to, emergency preparedness/security, budget formulation, self-determination issues, Tribal shares computations, and resolution of audit findings as may be needed and appropriate. Division of Information Technology
(1)Provides Chief Technology Officer IT services and advises the CIO on all aspects of IT;
(2)develops clinical and business practice healthcare applications such as the RPMS and the EHR;
(3)develops healthcare statistical applications for NPIRS;
(4)obtains system and business requirements from stakeholders for system design;
(5)provides quality assurance and risk management for software development;
(6)develops, implements, and maintains policies, procedures, and standards for system development and technology products and services in the IHS;
(7)develops and maintains IT strategic planning documents;
(8)develops and maintains the IHS enterprise architecture;
(9)develops and implements IT management initiatives in IHS;
(10)ensures IHS IT infrastructure resource consolidation and standardization efforts support IHS healthcare delivery and program administration;
(11)represents the IHS to Federal, Tribal, State, and other organizations; and
(12)participates in cross-cutting issues and processes that involve IT. Division of Program Management and Budget
(1)Advises the CIO on all business aspects of information resources and project management;
(2)develops information resource policies and procedures;
(3)develops the IHS IT budget and related documents;
(4)provides budget analyses and reports to the CIO;
(5)develops strategies for presenting the IHS IT budget to IHS, Tribal, and UIHP;
(6)provides technical analyses, guidance, and support for IHS capital planning and investment control activities;
(7)manages the IHS portfolio management tool;
(8)manages the activities of the IHS ITIRB in assessing, implementing and reviewing the Agency's information systems;
(9)develops project management policies and procedures;
(10)identifies alternatives among internal and external sources and recommends the best sources to supply information resource and technology products and services to IHS;
(11)develops information resource and technology project governance structures to support effective project management;
(12)provides project management and related support for IHS developed and acquired information resources and technology products and services;
(13)provides contract management support for IT initiatives;
(14)provides contract liaison services to appropriate acquisition authorities;
(15)participates in cross-cutting issues and processes that involve IT; and
(16)represents the IHS to Federal, Tribal, State, and other organizations. Division of Information Technology Operations
(1)Advises the CIO on all aspects of implementing and deploying computer systems including RPMS;
(2)installs and maintains enterprise computer systems and associated hardware and operating systems;
(3)installs and maintains enterprise application software;
(4)furnishes IRS-wide video conferencing solutions and services;
(5)delivers desktop and office automation support;
(6)provides 24 x 7 helpdesk support for RPMS and office applications;
(7)maintains LISTserv capabilities;
(8)provides customer relationship management support for IT systems;
(9)performs Web monitoring and filtering services;
(10)designs and implements Web sites in compliance with Section 508 Accessibility regulations;
(11)operates and maintains data centers;
(12)installs and supports e-mail, file, and print services;
(13)provides Domain Name Services;
(14)designs, implements, and maintains IHS's backbone network infrastructure;
(15)monitors network infrastructure for anomalies;
(16)provides project management support for systems design and deployment to ensure customer satisfaction;
(17)represents the IRS to Federal, Tribal, State, and other organizations; and
(18)participates in cross-cutting issues and processes that involve information resources and technology project management. Division of Information Security
(1)Advises the CIO on all aspects of information security;
(2)develops, implements, and monitors the IHS Information Security program to ensure adequate protection of information;
(3)develops and maintains information security policies, procedures, and guidelines to safeguard information and IT systems;
(4)develops and reviews IHS IT security plans;
(5)assesses the risk and magnitude of harm that could result from unauthorized access, use, disclosure, disruption, modification, or destruction of information and information systems that support the operations and assets of IHS;
(6)ensures that security and privacy have been incorporated in information system lifecycle plans;
(7)conducts vulnerability assessment of IHS's IT infrastructure;
(8)coordinates activities with internal and external organizations reviewing the IHS's information resources for fraud, waste, and abuse;
(9)develops and implements employee information security awareness training programs;
(10)manages the IHS Information Security Incident Response Team;
(11)represents the IHS to Federal, Tribal, State, and other organizations regarding information security; and
(12)participates in cross-cutting issues and processes that involve information security. This reorganization shall be effective July 17, 2008. Dated: July 8, 2008. Robert G. McSwain, Director, Indian Health Service [FR Doc. E8-16353 Filed 7-16-08; 8:45 am] BILLING CODE 4160-16-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Amended Notice of Meeting Notice is hereby given of a change in the meeting of the Center for Scientific Review Special Emphasis Panel, July 29, 2008, 7 a.m. to July 29, 2008, 7 p.m., National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD, 20892, which was published in the **Federal Register** on June 9, 2008, 73 FR 32589-32590. The meeting title has been changed to “EPR Shared Instrumentation Study Section. The meeting is closed to the public. Dated: July 3, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-15821 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* Center for Scientific Review Special Emphasis Panel; Special Topics in Neural Drug Discovery. *Date:* July 18, 2008. *Time:* 1 p.m. to 5 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). *Contact Person:* Mary Custer, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4148, MSC 7850, Bethesda, MD 20892-7850,
(301)435-1164, *custerm@csr.nih.gov.* This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: July 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-16146 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* Center for Scientific Review Special Emphasis Panel; ACTS Member Conflicts. *Date:* July 22, 2008. *Time:* 9 a.m. to 11:30 a.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). *Contact Person:* Richard J. Bartlett, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4110, MSC 7814, Bethesda, MD 20892, 301-435-6809, *bartletr@csr.nih.gov* . This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. *Name of Committee* : Center for Scientific Review Special Emphasis Panel; PBKD Member Conflict. *Date:* July 22, 2008. *Time:* 11 a.m. to 5 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). *Contact Person:* Shirley Hilden, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4222, MSC 7814, Bethesda, MD 20892,
(301)435-1198, *hildens@csr.nih.gov* . This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. *Name of Committee:* Center for Scientific Review Special Emphasis Panel; Family Planning Service Delivery Improvement Research. *Date:* July 22, 2008. *Time:* 1 p.m. to 5 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Virtual Meeting). *Contact Person:* Estina E. Thompson, MPH, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3178, MSC 7848, Bethesda, MD 20892, 301-496-5749, *thompsone@mail.nih.gov.* This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. *Name of Committee* : Center for Scientific Review Special Emphasis Panel; Review of HIV/AIDS Small Business and Other Applications. *Date:* July 25, 2008. *Time:* 11:30 a.m. to 2 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). *Contact Person:* Jose H. Guerrier, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 5218, MSC 7852, Bethesda, MD 20892, 301-435-1137, *guerriej@csr.nih.gov* . This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. *Name of Committee:* Center for Scientific Review Special Emphasis Panel; Member Conflicts: Musculoskeletal Rehabilitation Sciences. *Date:* August 4, 2008. *Time:* 12:30 p.m. to 3 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892, (Telephone Conference Call). *Contact Person:* John P. Holden, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4211, MSC 7814, Bethesda, MD 20892, 301-496-8551, *holdenjo@csr.nih.gov* . This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research; 93.306, 93.333, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: July 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-16147 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health Center for Scientific Review; Notice of Closed Meetings Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meetings. The meetings will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* Center for Scientific Review Special, Emphasis Panel Shared Instrumentation. *Date:* July 22, 2008. *Time:* 1 p.m. to 5 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting.) *Contact Person:* Jean D. Sipe, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 4106, MSC 7814, Bethesda, MD 20892, 301/435-1743, *sipe@csr.nih.gov.* This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. *Name of Committee:* Center for Scientific Review Special Emphasis Panel, Complex Genetics and Evolution. *Date:* July 23-25, 2008. *Time:* 2 p.m. to 12:30 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Telephone Conference Call.) *Contact Person:* Cheryl M. Corsaro, PhD, Scientific Review Officer, Center for Scientific Review National Institutes of Health, 6701 Rockledge Drive, Room 2204, MSC 7890, Bethesda, MD 20892,
(301)435-1045, *corsaroc@csr.nih.gov.* This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. *Name of Committee:* Center for Scientific Review, Special Emphasis Panel, Member Conflict: Health Risks, Interventions and Outcomes. *Date:* August 5, 2008. *Time:* 11 a.m. to 3 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting.) *Contact Person:* Michael Micklin, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 3136, MSC 7759, Bethesda, MD 20892,
(301)435-1258, *micklinm@csr.nih.gov.* This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. *Name of Committee:* Center for Scientific Review, Special Emphasis Panel, Diabetes, Obesity, and Energy Balance. *Date:* August 7-8, 2008. *Time:* 8 a.m. to 8 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6701 Rockledge Drive, Bethesda, MD 20892. (Virtual Meeting.) *Contact Person:* Ann A. Jerkins, PhD, Scientific Review Officer, Center for Scientific Review, National Institutes of Health, 6701 Rockledge Drive, Room 6154, MSC 7892, Bethesda, MD 20892, 301-435-4514, *jerkinsa@csr.nih.gov.* (Catalogue of Federal Domestic Assistance Program Nos. 93.306, Comparative Medicine; 93.333, Clinical Research, 93.337, 93.393-93.396, 93.837-93.844, 93.846-93.878, 93.892, 93.893, National Institutes of Health, HHS) Dated: July 10, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-16333 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* Environmental Health Sciences Review Committee; Environmental Health Sciences Core Center Grants. *Date:* July 22-23, 2008. *Time:* 8 p.m. to 1 p.m. *Agenda:* To review and evaluate grant applications. *Place:* Sheraton Chapel Hill, One Europa Drive, Chapel Hill, NC 27517. *Contact Person:* Linda K. Bass, PhD, Scientific Review Administrator, Nat'l Institute of Environmental Health Sciences, P.O. Box 12233, MD EC-24, Research Triangle Park, NC 27709,
(919)541-1307. This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: July 7, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-15823 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Environmental Health Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Institute of Environmental Health Sciences Special Emphasis Panel; Development of an ELISA for Measuring Serum Levels. *Date:* August 7, 2008. *Time:* 10 a.m. to 1 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* NIEHS/National Institutes of Health, Building 4401, East Campus, 79 T.W. Alexander Drive, Research Triangle Park, NC 27709 (Telephone Conference Call). *Contact Person:* RoseAnne M. McGee, Associate Scientific Review Officer, Scientific Review Branch, Division of Extramural Research and Training, National Institute of Environmental Health Sciences, P.O. Box 12233, MD EC-30, Research Triangle Park, NC 27709,
(919)541-0752, *mcgee1@niehs.nih.gov* . (Catalogue of Federal Domestic Assistance Program Nos. 93.115, Biometry and Risk Estimation—Health Risks from Environmental Exposures; 93.142, NIEHS Hazardous Waste Worker Health and Safety Training; 93.143, NIEHS Superfund Hazardous Substances—Basic Research and Education; 93.894, Resources and Manpower Development in the Environmental Health Sciences; 93.113, Biological Response to Environmental Health Hazards; 93.114, Applied Toxicological Research and Testing, National Institutes of Health, HHS) Dated: July 7, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-15824 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Institute on Aging Special Emphasis Panel Perceived Discrimination and Health Disparities. *Date:* August 1, 2008. *Time:* 9 a.m. to 12 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institute on Aging, Bethesda, MD 20892, (Telephone Conference Call). *Contact Person:* Jon E. Rolf, PhD, Scientific Review Administrator, Scientific Review Office, National Institute on Aging, Bethesda, MD 20814,
(301)402-7703, *rolfj@nia.nih.gov.* (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: July 3, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-15825 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Child Health and Human Development; Notice of Meeting Pursuant to section 10(a) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of a meeting of the National Children's Study Advisory Committee. The meeting will be open to the public, with attendance limited to space available. Individuals who plan to attend and need special assistance, such as sign language interpretation or other reasonable accommodations, should notify the Contact Person listed below in advance of the meeting. *Name of Committee:* National Children's Study Advisory Committee. *Date:* August 7, 2008. *Time:* 10 a.m. to 3 p.m. *Agenda:* The National Academy of Sciences
(NAS)recently released its review of the National Children's Study
(NCS)Research Plan. A NCS Federal Advisory Committee Meeting is being convened to discuss the NAS recommendations and the NCS response. For more information on the NAS review, please go to *http://nationalchildrensstudy.gov/news/e-updates/research_planjeview_may_2008.cfm* . *Place:* Westat Conference Center, 1600 Research Blvd., 5th Floor—Rooms A & B, Rockville, MD 20850. *Contact Person:* Jessica Sapjenza, Adjunct Study Program Analyst, National Children's Study, Eunice Kennedy Shriver National Institute, of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5C01, Bethesda, MD 20892,
(703)902-1339, *ncsinfo@mail.nih.gov* . Any interested person may file written comments with the committee by forwarding the statement to the Contact Person listed on this notice. The statement should include the name, address, telephone number and when applicable, the business or professional affiliation of the interested person. (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: July 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-16141 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of General Medical Sciences; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Institute of General Medical Sciences Special Emphasis Panel, Burn Injury Phase III Clinical Trial. *Date:* August 6, 2008. *Time:* 8:30 a.m. to 5 p.m. *Agenda:* To review and evaluate grant applications. *Place:* Westin Embassy Row, 2100 Massachusetts Avenue, NW., Washington, DC 20008. *Contact Person:* Brian R. Pike, PhD, Scientific Review Officer, Office of Scientific Review, National Institute of General Medical Sciences, National Institutes of Health, 45 Center Drive, Room 3AN18, Bethesda, MD 20892, 301-594-3907, *pikbr@mail.nih.gov* . (Catalogue of Federal Domestic Assistance Program Nos. 93.375, Minority Biomedical Research Support; 93.821, Cell Biology and Biophysics Research; 93.859, Pharmacology, Physiology, and Biological Chemistry Research; 93.862, Genetics and Developmental Biology Research; 93.88, Minority Access to Research Careers; 93.96, Special Minority Initiatives, National Institutes of Health, HHS) Dated: July 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-16142 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Institute of Allergy and Infectious Diseases Special Emphasis Panel; Teleconference Review of the Kraft P01 Application. *Date:* July 31, 2008. *Time:* 12 p.m. to 3 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6700B Rockledge Drive, Bethesda, MD 20817 (Telephone Conference Call). *Contact Person:* Quirijn Vos, PhD, Scientific Review Officer, Scientific Review Program, Division of Extramural Activities, National Institutes of Health/NIAID, 6700B Rockledge Drive, MSC 7616, Bethesda, MD 20892, 301-451-2666, *qvos@niaid.nih.gov.* This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.855, Allergy, Immunology, and Transplantation Research; 93.856, Microbiology and Infectious Diseases Research, National Institutes of Health, HHS) Dated: July 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-16143 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute on Aging; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Institute on Aging Special Emphasis Panel GWAS. *Date:* August 15, 2008. *Time:* 11 a.m. to 1 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes on Aging, Gateway Building, 7201 Wisconsin Avenue, Room 2C212, Bethesda, MD 20814. (Telephone Conference Call.) *Contact Person:* Ramesh Vemuri, PhD, Scientific Review Office, National Institute on Aging, National Institutes of Health, 7201 Wisconsin Avenue, Suite 2C-212, Bethesda, MD 20892, 301-402-7700, *rv23r@nih.gov.* (Catalogue of Federal Domestic Assistance Program Nos. 93.866, Aging Research, National Institutes of Health, HHS) Dated: July 10, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-16336 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The contract proposals and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the contract proposals, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Institute of Child Health and Human Development Special Emphasis Panel; Best Pharmaceuticals for Children Act
(BPCA)Repository. *Date:* August 15, 2008. *Time:* 8 a.m. to 5 p.m. *Agenda:* To review and evaluate contract proposals. *Place:* Hyatt Regency Bethesda, One Bethesda Metro Center, 7400 Wisconsin Avenue, Bethesda, MD 20814. *Contact Person:* Sathasiva B. Kandasamy, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, 6100 Executive Boulevard, Room 5b01, Bethesda, MD 20892-9304,
(301)435-6680, *skandasa@mail.nih.gov* . (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: July 11, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-16399 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Institute of Diabetes and Digestive and Kidney Diseases Special Emphasis Panel; Metabolism Interdisciplinary Studies. *Date:* July 31, 2008. *Time:* 1 p.m. to 4 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, Two Democracy Plaza, 6707 Democracy Boulevard, Bethesda, MD 20892, (Telephone Conference Call). *Contact Person:* Robert Wellner, PhD, Scientific Review Officer, Review Branch, DEA, NIDDK, National Institutes of Health, Room 757, 6707 Democracy Boulevard, Bethesda, MD 20892-5452, *rw175w@nih.gov.* This notice is being published less than 15 days prior to the meeting due to the timing limitations imposed by the review and funding cycle. (Catalogue of Federal Domestic Assistance Program Nos. 93.847, Diabetes, Endocrinology and Metabolic Research; 93.848, Digestive Diseases and Nutrition Research; 93.849, Kidney Diseases, Urology and Hematology Research, National Institutes of Health, HHS) Dated: July 11, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-16405 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Institute of Child Health and Human Development; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Institute of Child Health and Human Development Special Emphasis Panel; Innovative Therapies and Clinical Studies for Screenable Disorders.” *Date:* August 12, 2008. *Time:* 1 p.m. to 3:30 p.m. *Agenda:* To review and evaluate grant applications. *Place:* National Institutes of Health, 6100 Executive Boulevard, Room 5B01, Rockville, MD 20852, (Telephone Conference Call). *Contact Person:* Norman Chang, PhD, Scientific Review Administrator, Division of Scientific Review, National Institute of Child Health and Human Development, NIH, 6100 Executive Blvd., Room 5b01, Bethesda, MD 20892,
(301)496-1485, *changn@mail.nih.gov.* (Catalogue of Federal Domestic Assistance Program Nos. 93.864, Population Research; 93.865, Research for Mothers and Children; 93.929, Center for Medical Rehabilitation Research; 93.209, Contraception and Infertility Loan Repayment Program, National Institutes of Health, HHS) Dated: July 11, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-16406 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-P DEPARTMENT OF HEALTH AND HUMAN SERVICES National Institutes of Health National Library of Medicine; Notice of Closed Meeting Pursuant to section 10(d) of the Federal Advisory Committee Act, as amended (5 U.S.C. Appendix 2), notice is hereby given of the following meeting. The meeting will be closed to the public in accordance with the provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 U.S.C., as amended. The grant applications and the discussions could disclose confidential trade secrets or commercial property such as patentable material, and personal information concerning individuals associated with the grant applications, the disclosure of which would constitute a clearly unwarranted invasion of personal privacy. *Name of Committee:* National Library of Medicine Special Emphasis Panel; Scholary Work
(G13)SEP. *Date:* September 12, 2008. *Time:* 8:30 a.m. to 5 p.m. *Agenda:* To review and evaluate grant applications. *Place:* Embassy Suites at the Chevy Chase Pavilion, 4300 Military Road, NW., Washington, DC 20015. *Contact Person:* Zoe E. Huang, MD, Scientific Review Officer, Division of Extramural Programs, National Library of Medicine, National Institutes of Health, 6705 Rockledge Drive, Suite 301, Msc 7968, Bethesda, MD 20892-7968,
(301)594-4937, *huangz@mail.nih.gov* . (Catalogue of Federal Domestic Assistance Program Nos. 93.879, Medical Library Assistance, National Institutes of Health, HHS) Dated: July 9, 2008. Jennifer Spaeth, Director, Office of Federal Advisory Committee Policy. [FR Doc. E8-16144 Filed 7-16-08; 8:45 am] BILLING CODE 4140-01-M DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR-5187-N-44] Multifamily Insurance Benefits Claims Package AGENCY: Office of the Chief Information Officer, HUD. ACTION: Notice. SUMMARY: The proposed information collection requirement described below has been submitted to the Office of Management and Budget
(OMB)for review, as required by the Paperwork Reduction Act. The Department is soliciting public comments on the subject proposal. When the terms of a Multifamily contract are breached or when a mortgagee meets conditions stated within the Multifamily contract for an automatic assignment, the holder of the mortgage may file for insurance benefits. To receive these benefits, the mortgagee must prepare and submit to HUD the Multifamily Insurance Benefits Claims Package. HUD uses the information collection to determine the insurance benefits owed to the mortgagee. DATES: *Comments Due Date:* August 18, 2008. ADDRESSES: Interested persons are invited to submit comments regarding this proposal. Comments should refer to the proposal by name and/or OMB approval Number (2502-0418) and should be sent to: HUD Desk Officer, Office of Management and Budget, New Executive Office Building, Washington, DC 20503; fax: 202-395-6974. FOR FURTHER INFORMATION CONTACT: Lillian Deitzer, Reports Management Officer, QDAM, Department of Housing and Urban Development, 451 Seventh Street, SW., Washington, DC 20410; e-mail Lillian Deitzer at *Lillian_L_Deitzer@HUD.gov* or telephone
(202)402-8048. This is not a toll-free number. Copies of available documents submitted to OMB may be obtained from Ms. Deitzer. SUPPLEMENTARY INFORMATION: This notice informs the public that the Department of Housing and Urban Development has submitted to OMB a request for approval of the Information collection described below. This notice is soliciting comments from members of the public and affecting agencies concerning the proposed collection of information to:
(1)Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
(2)Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information;
(3)Enhance the quality, utility, and clarity of the information to be collected; and
(4)Minimize the burden of the collection of information on those who are to respond; including through the use of appropriate automated collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. This Notice Also Lists the Following Information *Title of Proposal:* Multifamily Insurance Benefits Claims Package. *OMB Approval Number:* 2502-0418. *Form Numbers:* HUD-2741, HUD-2742, HUD-2744-A, HUD-2744-B, HUD-2744-C, HUD-2744-D, HUD-2744-E, HUD-434, and HUD-1044-D. *Description of the Need for the Information and its Proposed Use:* When the terms of a Multifamily contract are breached or when a mortgagee meets conditions stated within the Multifamily contract for an automatic assignment, the holder of the mortgage may file for insurance benefits. To receive these benefits, the mortgagee must prepare and submit to HUD the Multifamily Insurance Benefits Claims Package. HUD uses the information collection to determine the insurance benefits owed to the mortgagee. *Frequency of Submission:* On occasion. Number of respondents Annual responses × Hours per response = Burden hours Reporting Burden 150 9 0.47 637 *Total Estimated Burden Hours:* 637. *Status:* Extension of a currently approved collection. Authority: Section 3507 of the Paperwork Reduction Act of 1995, 44 U.S.C. 35, as amended. Dated: July 10, 2008. Lillian L. Deitzer, Departmental Paperwork Reduction Act Officer, Office of the Chief Information Officer. [FR Doc. E8-16325 Filed 7-16-08; 8:45 am] BILLING CODE 4210-67-P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR-5187-N-42] Certification of Multifamily Housing Compliance With State and Local Housing Codes AGENCY: Office of the Chief Information Officer, HUD. ACTION: Notice. SUMMARY: The proposed information collection requirement described below has been submitted to the Office of Management and Budget
(OMB)for review, as required by the Paperwork Reduction Act. The Department is soliciting public comments on the subject proposal. This collection is necessary for HUD to ensure that all properties owned by potential purchasers are in compliance with the state and local housing codes that are in the same locality as the project to be purchased. DATES: *Comments Due Date:* August 18, 2008. ADDRESSES: Interested persons are invited to submit comments regarding this proposal. Comments should refer to the proposal by name and/or OMB approval Number (2502-0559) and should be sent to: HUD Desk Officer, Office of Management and Budget, New Executive Office Building, Washington, DC 20503; fax: 202-395-6974. FOR FURTHER INFORMATION CONTACT: Lillian Deitzer, Reports Management Officer, QDAM, Department of Housing and Urban Development, 451 Seventh Street, SW., Washington, DC 20410; e-mail Lillian Deitzer at *Lillian_L_Deitzer@HUD.gov* or telephone
(202)402-8048. This is not a toll-free number. Copies of available documents submitted to OMB may be obtained from Ms. Deitzer. SUPPLEMENTARY INFORMATION: This notice informs the public that the Department of Housing and Urban Development has submitted to OMB a request for approval of the Information collection described below. This notice is soliciting comments from members of the public and affecting agencies concerning the proposed collection of information to:
(1)Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
(2)Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information;
(3)Enhance the quality, utility, and clarity of the information to be collected; and
(4)Minimize the burden of the collection of information on those who are to respond; including through the use of appropriate automated collection techniques or other forms of information technology, e.g., permitting electronic submission of responses. This Notice Also Lists the Following Information *Title of Proposal:* Certification of Multifamily Housing Compliance with State and Local Housing Codes. *OMB Approval Number:* 2502-0559. *Form Numbers:* HUD-9840. *Description of the Need for the Information and its Proposed Use:* This collection is necessary for HUD to ensure that all properties owned by potential purchasers are in compliance with the state and local housing codes that are in the same locality as the project to be purchased. *Frequency of Submission:* On occasion. Number of respondents Annual responses × Hours per response = Burden hours Reporting Burden 14,758 .0008 .25 3 *Total Estimated Burden Hours:* 3. *Status:* Revision of a currently approved collection. Authority: Section 3507 of the Paperwork Reduction Act of 1995, 44 U.S.C. 35, as amended. Dated: July 10, 2008. Lillian L. Deitzer, Departmental Paperwork Reduction Act Officer, Office of the Chief Information Officer. [FR Doc. E8-16326 Filed 7-16-08; 8:45 am] BILLING CODE 4210-67-P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR-5187-N-43] Application for Displacement/Relocation/Temporary Relocation Assistance for Person AGENCY: Office of the Chief Information Officer, HUD. ACTION: Notice. SUMMARY: The proposed information collection requirement described below has been submitted to the Office of Management and Budget
(OMB)for review, as required by the Paperwork Reduction Act. The Department is soliciting public comments on the subject proposal. Application for displacement/relocation assistance for person (families, individuals, businesses, nonprofit organizations and farms) displaced by certain HUD programs, or for out-of-pocket expenses incurred by persons temporarily relocated for a HUD-assisted program or project. Periodically, HUD reviews a random sample of the Agency files to assure that persons received the relocation payments to which they are entitled. DATES: *Comments Due Date:* August 18, 2008. ADDRESSES: Interested persons are invited to submit comments regarding this proposal. Comments should refer to the proposal by name and/or OMB approval Number (2506-0016) and should be sent to: HUD Desk Officer, Office of Management and Budget, New Executive Office Building, Washington, DC 20503; fax: 202-395-6974. FOR FURTHER INFORMATION CONTACT: Lillian Deitzer, Reports Management Officer, QDAM, Department of Housing and Urban Development, 451 Seventh Street, SW., Washington, DC 20410; e-mail Lillian Deitzer at *Lillian_L_Deitzer@HUD.gov* or telephone
(202)402-8048. This is not a toll-free number. Copies of available documents submitted to OMB may be obtained from Ms. Deitzer. SUPPLEMENTARY INFORMATION: This notice informs the public that the Department of Housing and Urban Development has submitted to OMB a request for approval of the Information collection described below. This notice is soliciting comments from members of the public and affecting agencies concerning the proposed collection of information to:
(1)Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
(2)Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information;
(3)Enhance the quality, utility, and clarity of the information to be collected; and
(4)Minimize the burden of the collection of information on those who are to respond; including through the use of appropriate automated collection techniques or other forms of information technology, *e.g.* , permitting electronic submission of responses. This Notice Also Lists the Following Information *Title of Proposal:* Application for displacement/relocation assistance for person (families, individuals, businesses, nonprofit organizations and farms) displaced by certain HUD programs, or for out-of-pocket expenses incurred by persons temporarily relocated for a HUD-assisted program or project. Periodically, HUD reviews a random sample of the Agency files to assure that persons received the relocation payments to which they are entitled. *OMB Approval Number:* 2506-0016. *Form Numbers:* HUD-40030, HUD-40054, HUD-40055, HUD-40056, HUD-40057, HUD-40058, HUD-40061, HUD-40072. *Description of the Need for the Information and its Proposed Use:* Application for displacement/relocation assistance for person (families, individuals, businesses, nonprofit organizations and farms) displaced by certain HUD programs, or for out-of-pocket expenses incurred by persons temporarily relocated for a HUD-assisted program or project. Periodically, HUD reviews a random sample of the Agency files to assure that persons received the relocation payments to which they are entitled. *Frequency of Submission:* Recordkeeping. Number of respondents Annual responses × Hours per response = Burden hours Reporting Burden 37,800 1.62 0.90 56,000 *Total Estimated Burden Hours:* 56,000. *Status:* Revision of a currently approved collection. Authority: Section 3507 of the Paperwork Reduction Act of 1995, 44 U.S.C. 35, as amended. Dated: July 10, 2008. Lillian L. Deitzer, Departmental Paperwork Reduction Act Officer, Office of the Chief Information Officer. [FR Doc. E8-16327 Filed 7-16-08; 8:45 am] BILLING CODE 4210-67-P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR-5187-N-41] Land Survey Report for Insured Multifamily Projects AGENCY: Office of the Chief Information Officer, HUD. ACTION: Notice. SUMMARY: The proposed information collection requirement described below has been submitted to the Office of Management and Budget
(OMB)for review, as required by the Paperwork Reduction Act. The Department is soliciting public comments on the subject proposal. Borrowers submit a land survey and related information to secure a marketable title and title insurance for multifamily project mortgage insurance. The submission is made at application and at closing. DATES: *Comments Due Date:* August 18, 2008. ADDRESSES: Interested persons are invited to submit comments regarding this proposal. Comments should refer to the proposal by name and/or OMB Approval Number (2502-0010) and should be sent to: HUD Desk Officer, Office of Management and Budget, New Executive Office Building, Washington, DC 20503; fax: 202-395-6974. FOR FURTHER INFORMATION CONTACT: Lillian Deitzer, Reports Management Officer, QDAM, Department of Housing and Urban Development, 451 Seventh Street, SW., Washington, DC 20410; e-mail Lillian Deitzer at *Lillian_L_Deitzer@HUD.gov* or telephone
(202)402-8048. This is not a toll-free number. Copies of available documents submitted to OMB may be obtained from Ms. Deitzer. SUPPLEMENTARY INFORMATION: This notice informs the public that the Department of Housing and Urban Development has submitted to OMB a request for approval of the Information collection described below. This notice is soliciting comments from members of the public and affecting agencies concerning the proposed collection of information to:
(1)Evaluate whether the proposed collection of information is necessary for the proper performance of the functions of the agency, including whether the information will have practical utility;
(2)Evaluate the accuracy of the agency's estimate of the burden of the proposed collection of information;
(3)Enhance the quality, utility, and clarity of the information to be collected; and
(4)Minimize the burden of the collection of information on those who are to respond; including through the use of appropriate automated collection techniques or other forms of information technology, *e.g.* , permitting electronic submission of responses. This Notice Also Lists the Following Information *Title of Proposal:* Land Survey Report for Insured Multifamily Projects. *OMB Approval Number:* 2502-0010. *Form Numbers:* HUD-92457. *Description of the Need for the Information and its Proposed Use:* Borrowers submit a land survey and related information to secure a marketable title and title insurance for multifamily project mortgage insurance. The submission is made at application and at closing. *Frequency of Submission:* On occasion. Number of respondents Annual responses × Hours per response = Burden hours Reporting Burden 800 2 .5 800 *Total Estimated Burden Hours:* 800. *Status:* Extension of a currently approved collection. Authority: Section 3507 of the Paperwork Reduction Act of 1995, 44 U.S.C. 35, as amended. Dated: July 10, 2008. Lillian L. Deitzer, Departmental Paperwork Reduction Act Officer, Office of the Chief Information Officer. [FR Doc. E8-16328 Filed 7-16-08; 8:45 am] BILLING CODE 4210-67-P DEPARTMENT OF HOUSING AND URBAN DEVELOPMENT [Docket No. FR-5130-N-26] Privacy Act; Proposed New Systems of Records, Single Family Mortgage Asset Recovery Technology (SMART/A80H) AGENCY: Office of the Chief Information Officer, HUD. ACTION: Establishment of a new Privacy Act System of Records. SUMMARY: The Department of Housing and Urban Development HUD proposes to establish a new record system to add to its inventory of systems of records subject to the Privacy Act of 1974 (5 U.S.C. 552a), as amended. The proposed new system of record is the Single Family Mortgage Asset Recovery Technology (SMART). The SMART system will be used for accounting level detail on forward and reverse mortgages; case-tracking ability; report generating capability; query functions; database management, analyzing, processing, and tracking for FHA Insured and Secretary-held first, second and subordinate note and mortgage loan servicing functions. DATES: *Effective Date:* This action shall be effective without further notice on August 18, 2008 unless comments are received that would result in a contrary determination. *Comments Due Date:* August 18, 2008. ADDRESSES: Interested persons are invited to submit comments regarding this notice to the Rules Docket Clerk, Office of General Counsel, Room 10276, Department of Housing and Urban Development, 451 Seventh Street, SW., Washington, DC 20410. Communications should refer to the above docket number and title. A copy of each communication submitted will be available for public inspection and copying between 8 a.m. and 5 p.m. weekdays at the above address. FOR FURTHER INFORMATION CONTACT: Donna Robinson-Staton, Departmental Privacy Act Officer, Department of Housing and Urban Development, 451 Seventh St., SW., Room 4178, Washington, DC 20410, Telephone Number
(202)402-8073. (This is not a toll-free number.) A telecommunication device for hearing- and speech-impaired individuals
(TTY)is available at 1-800-877-8339 (Federal Information Relay Service). SUPPLEMENTARY INFORMATION: Pursuant to the Privacy Act of 1974 (5 U.S.C. 552a), as amended notice is given that HUD proposes to establish a new system of records as identified as the SMART, HUD/HS-58 Title 5 U.S.C. 552a(e)(4) and
(11)provide that the public be afforded a 30-day period in which to comment on the new system of records, and require published notice of the existence and character of the system of records. The new system report was submitted to the Office of Management and Budget (OMB), the Senate Committee on Governmental Affairs, and the House Committee on Government Reform pursuant to paragraph 4c of Appendix 1 to OMB Circular No. A-130, “Federal Agency Responsibilities for Maintaining Records About Individuals,” July 25, 1994; 59 FR 37914. Authority: 5 U.S.C. 552a 88 Stat. 1896; 342 U.S.C. 3535(d). Dated: July 10, 2008. Joseph M. Milazzo, Chief Information Officer. HUD/HS-58 System Name: Single Family Mortgage Asset Recovery Technology (SMART). System Location: Morris-Griffin Corporation (Sub-Contractor site), Lanham, Maryland; C & L Service Corporation/Morris-Griffin Corporation (Contractor/Sub-Contractor site), Tulsa, Oklahoma (Access for HUD users are through a Citrix Server). Categories of individuals covered by the system: Mortgagors (Secretary-Held First, Second and Subordinate Note and mortgages). Categories of records in the System: Mortgagor's name, Spouse name, social security number, loan number, date or birth, property address, home telephone, personal email address, telephone number, FHA case number, and income financial data. Authority for maintenance of the system: Sec. 204, National Housing Act, 12 U.S.C. 1710(a) in general. Purposes: The information is used to perform a wide range of FHA Insured and Secretary-held first, second and subordinate note and mortgage loan servicing functions. The SMART System is a comprehensive loan servicing system that processes the mortgage transactions for both forward and reverse mortgages, including interest, appreciation, amortization and other agreed calculations for the Secretary-Owned Title II Portfolio. Routine uses of records maintained in the system, including categories of users and the purposes of such uses: In addition to those disclosures generally permitted under 5 U.S.C. 552a(b) of the Privacy Act, other routine uses are as follows:
(a)To the U.S. Treasury—for disbursements and adjustments; and
(b)To the Internal Revenue Service—for reporting payments for mortgage interest, for reporting of discharge indebtedness and real estate taxes. Policies and practices for storing, retrieving, accessing, retaining, and disposing of records in the system: Storage: Electronic files are stored on servers and back up files are stored on tapes. Servers are stored in a secured server room and at an offsite secured facility for disaster contingency. Retrievability: Information can only be retrieved by Mortgagor's name, SSN, FHA Case Number, and home address. Only individuals with rights to the full/limited access can view this type of information. Safeguards: The original collateral documents (hard copy) are stored at the Contractors office site for all open loans and the closed documents are stored at a secured offsite document storage facility. All hard copy files are stored within a secured room within the Contractor's secured office suite when not in use. Background screening, limited authorizations and access, with access limited to authorized personnel and technical restraints employed with regard to accessing the records; access to automated systems by authorized users by passwords. Retention and disposal: Are in accordance with HUD Records Disposition Schedule 2225.6, Appendix 20. System Manager(s) and address: Sharon Lundstrom, Director, Housing, Office of Single Family Asset Management, Servicing & Loss Mitigation Division (a/k/a National Servicing Center), Tulsa, Oklahoma, Department of Housing and Urban Development, National Servicing Center, Tulsa, Oklahoma, Telephone Number
(405)609-8443. Notification procedure: For information assistance, or inquiry about existence of records, contact Donna Robinson-Staton, Departmental Privacy Act Officer, Department of Housing and Urban Development, 451 Seventh Street, SW., Room 2256, Washington, DC 20410, Telephone Number
(202)402-8073. Record access procedures: The Department's rules for providing access to records to the individual concerned appear in 24 CFR part 16. If additional information or assistance is required, contact the Departmental Privacy Act Officer, Department of Housing and Urban Development, 451 Seventh Street, SW., Room 2256, Washington, DC 20410. Contesting record procedures: The procedures for requesting amendment or correction of records appear in 24 CFR part 16. If additional information is needed, contact:
(i)In relation to contesting contents of records, the Departmental Privacy Act Officer at HUD, 451 Seventh Street, SW., Room 2256, Washington, DC 20410; and
(ii)In relation to appeals of initial denials, HUD, Departmental Privacy Appeals Officer, Office of General Counsel, 451 Seventh Street, SW., Washington, DC 20410. Record source categories: The original information was transferred from an access database program; records were also established using the legal instruments (i.e., mortgage, deed, subordinate mortgage, etc.) received from the mortgagees; and loan balances were taken from F12 (IACS). New loan data is currently loaded via upload of data through a FTR from CHUMS(F17) and IACS(F12), and the legal instruments. Exemptions from certain provisions of the Act: None. [FR Doc. E8-16339 Filed 7-16-08; 8:45 am] BILLING CODE 4210-67-P INTER-AMERICAN FOUNDATION Sunshine Act Meetings; Board Meeting Time and Date: July 28, 2008, 9 a.m.-2:30 p.m. Place: 901 N. Stuart Street, Tenth Floor, Arlington, Virginia 22203. Status: Open to the public. Matters to be Considered: • Approval of the Minutes of the January 28, 2008, Meeting of the Board of Directors • President's Report • Program Update • Operations Update • Congressional Affairs Update • RedEAmérica/Corporate Partnership Update • Planning for the IAF's 40th Anniversary • Advisory Council Portions to be Open to the Public: • Approval of the Minutes of the January 28, 2008, Meeting of the Board of Directors • President's Report • Program Update • Operations Update • Congressional Affairs Update • RedEAmérica/Corporate Partnership Update • Planning for the IAF's 40th Anniversary • Advisory Council Contact Person for More Information: Rebecca B. Verreau,
(703)306-4314 Dated: July 14, 2008. Rebecca B. Verreau, Attorney. [FR Doc. 08-1444 Filed 7-15-08; 3:31 pm]
Connectionstraces to 9
19 references not yet in our index
  • 45 CFR 1355.50
  • 45 CFR 98.17
  • 44 USC 3501-3520
  • 21 CFR 601
  • 21 CFR 56
  • 21 CFR 801
  • 21 CFR 807
  • 21 CFR 812
  • 21 CFR 820
  • 5 USC 601-602
  • Pub. L. 104-121
  • Pub. L. 92-463
  • 41 CFR 102
  • Pub. L. 94-437
  • 45 CFR 74
  • 44 USC 35
  • 88 Stat. 1896
  • 342 USC 3535(d)
  • 24 CFR 16
Citation graph
cites case law
Notices
Notice
U.S.C.§ 3506
C.F.R.§ 10.115
U.S.C.§ 360
U.S.C.§ 300b–10
U.S.C.§ 1652
U.S.C.§ 1603
Fed. Reg.Notices
U.S.C.§ 552a
U.S.C.§ 1710
Cite45 CFR 1355.50
Cite45 CFR 98.17
Cite44 USC 3501-3520
Cites 28 · showing 12Cited by 0 across 0 sources
★   the supreme law of the land   ★
Don't Tread on Me
E Pluribus Unum — out of many, one

"If you don't know your rights, you don't have any."

Marginalia · a citizen's law index
A research desk, not legal advice. Always read the cited source before relying on a summary.
Questions or an issue? support@self-law.org
disclaimerMarginalia is a research index, not a law firm. Nothing on this site is legal, tax, or financial advice and no attorney–client relationship is formed by using it. Statutes, regulations, and case law change; summaries, search results, AI output, and member posts may be incomplete, out of date, or wrong. Any interpretation drawn from material on this site should be validated by a licensed attorney in your jurisdiction before you act on it.